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Abstract
In the United States, smoking causes preventable diseases, including lung cancer,
which is the leading cause of cancer deaths. Improving smoking cessation rates is
important to decrease lung cancer deaths. Health care visits with a discussion about lung
cancer screening (LCS) may help in increasing prevalence of smoking cessation.
Importantly, insurers now require clinicians to have a shared decision-making discussion
with patients that includes discussion of smoking abstinence before they can receive an
LCS scan (i.e., a low-dose computed tomography scan). This discussion may represent a
unique opportunity to encourage smoking cessation since it may prompt positive smoking
behavior change. However, it is less known whether, and to what extent, factors are
important for current smoking status or improving smoking cessation before and within
the LCS decision-making discussion.
This three-paper dissertation aims to understand patterns of successful smoking
cessation focusing on socioeconomic, sociodemographic, and psychosocial factors among
patients offered LCS at three sites: VA Portland Health Care System, VA Minneapolis
Health Care System, and Duke University Medical Center. I utilize both quantitative and
qualitative approaches to examine data from an existing longitudinal dataset compiled by
the VA Portland Health Care System, which includes patient survey responses, electronic
health records, and patient and clinician interviews. For the first paper, I describe the
socioeconomic and sociodemographic factors of patients offered LCS and compare
factors of those who had successfully quit smoking prior to being offered LCS with the
factors of those who were not successfully able to quit. For the second paper, I examine
i

how patient-reported presence of patient-clinician communication is associated with
smoking cessation (measured at one-year follow-up). For the third paper, I qualitatively
evaluate how clinicians and patients communicate about smoking in the context of the
LCS decision-making discussion. With this analysis, I can explore the nuances of how
patients and clinicians communicate about smoking in the context of lung cancer
screening.
Given that conversations between patients and clinicians pertaining to smoking
may serve as a unique opportunity for smoking cessation, this dissertation provides better
understandings about roles of communications with clinicians in smoking cessations
among patients. First, I found that hardened smokers offered LCS differed in important
social factors based on their smoking status at baseline. Second, discussing smoking
cessation during the LCS decision-making discussion may not lead to successful smoking
cessation at least in the short term. There may be other more important aspects that affect
smoking cessation. Lastly, in support of previous findings, communication about
smoking during the LCS decision-making discussion is unlikely to influence smoking
behavior. Findings of the three analytic chapters can offer some insights for how the LCS
decision-making discussion is helpful to encourage cessation, which would improve
public health by reducing deaths from lung related diseases.
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Chapter 1. Introduction
It is well known that cigarette smoking undermines health (Centers for Disease
Control and Prevention 2018a; Cesar Neto et al. 2012; Dunga et al. 2015; Feirman et al.
2016; Sanner and Grimsrud 2015; Taylor 2015; U.S. Department of Health and Human
Services 2014; Warnakulasuriya et al. 2010; Warren and Cummings 2013). Smoking
remains the leading cause of preventable disease in the United States (Centers for Disease
Control and Prevention [CDC] 2018a) and is associated with 80-90% of all lung cancers.
Indeed, while lung cancer is the third most commonly diagnosed cancer, the fatality rate
of lung cancer is the highest among all cancers (Siegel, Miller, and Jemal 2016).
Smoking cessation can significantly reduce morbidity and mortality risks (CDC 2018b;
U.S. Department of Health and Human Services 2014). However, approximately 14% of
US adults continue to smoke (CDC 2018c), despite widespread knowledge about its
harmful effects. Lung cancer screening (LCS) using an annual low-dose computed
tomography (LDCT) scan is another avenue to reduce morbidity and mortality from
cigarette smoking (herein, ‘LCS’ refers to the process of screening while ‘LDCT’ refers
to the scan itself). Importantly, insurers now require a shared decision-making discussion
(herein, referred to as the “decision-making discussion”) to occur prior to patient receipt
of the LDCT that includes discussion of smoking cessation and abstinence. It is unknown
what factors are important for improving smoking cessation among patients offered the
LDCT for LCS during the decision-making discussion.
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The purpose of this dissertation is to describe and examine patterns of successful
smoking cessation using socioeconomic, sociodemographic, and psychosocial factors,
while understanding use of the LCS decision-making discussion as an opportunity to
encourage cessation. Given that conversations between patients and clinicians pertaining
to smoking may serve as a unique opportunity for smoking cessation, this dissertation
provides better understandings about roles of communications with clinicians in smoking
cessations among patients. Findings of the three analytic chapters can offer insights for
how the LCS decision-making discussion is helpful to encourage cessation, which would
improve public health by reducing deaths from lung related diseases.
For this purpose, I aim to address three research questions in this dissertation. My
first research question examines whether patients who were able to successfully achieve
smoking cessation differ from patients who were not able to successfully achieve
smoking cessation in terms of socioeconomic and sociodemographic factors. My second
research question investigates the role of communication within the LCS decisionmaking discussion in smoking cessation. To address this question, I look at patientclinician communication (assessed by patient’s perceptions of the presence of
communication about smoking) during the LCS decision-making discussion associated
with smoking cessation. Finally, I address a question of how clinicians and patients
communicate about smoking within the LCS decision-making discussion.
To address my first research question, I describe and compare various social
factors of patients participating in LCS programs at three separate sites. Patients offered
LCS can be classified as hardened smokers (those who have a difficult time quitting). I
2

describe the role of the socioeconomic status (SES), measured by educational attainment,
employment status, and income, as well as sociodemographic factors among the patients.
I then perform bivariate analysis to compare those who were able to successfully quit
smoking with those who were not able to successfully quit prior to being offered LCS, in
terms of SES and sociodemographic factors. Given the large body of research connecting
higher SES and certain demographics to improved health outcomes (Kawachi et al. 1997;
Mirowsky and Ross 2015; Phelan et al. 2004; Phelan, Link, and Tehranifar 2010;
Schnittker 2004; Subramanian and Kawachi 2004), it is expected that individuals of less
education, who are not employed, have lower income, are of minority racial/ethnic status,
are not married, and are male, would be less likely to report successful smoking cessation
compared to those who have more education, who are employed, have higher income, are
non-minorities, are married, and are female (Gorini et al. 2018; Jha et al. 2006; Royal
College of Physicians 2016). Because differences in SES exist among patients at the
study sites, I also expect that patients at the VAPORHCS or Minneapolis sites are less
likely to report successful smoking cessation, compared to those who are at the Duke site.
After I describe and compare these social factors in terms of smoking cessation
for the first research question, I examine the independent contribution of an important
psychosocial resource on successful smoking cessation by looking at patient-clinician
communication. Because treatment compliance and improved health outcomes can be
improved with communication, and communication is prompted by shared decisionmaking, I assess the contribution of patient-clinician communication. Patient-clinician
communication is a psychosocial factor that is increasingly recognized as an important
3

determinant of health. High-quality communication can improve patient-centered
outcomes like smoking cessation and abstinence, as well as increased exercise and other
positive health behaviors (Institute of Medicine [IOM] 2013; Mead and Bower 2000;
Simpson et al. 1991; Weiland et al. 2012). Thus, I expect that individuals reporting
communication about smoking cessation with their clinician will be more likely to
evidence successful smoking cessation at the end of the study period.
Finally, Research Question 3 (RQ3) undertakes a qualitative examination of the
nuances of how patients and clinicians communicate about smoking in the context of
LCS. RQ3 thus sheds light on the previous quantitative RQ2. This study asks: How do
clinicians and patients communicate about smoking during the LCS decision-making
discussion? The qualitative examination uses conventional content analysis to add to the
richness of the prior research questions. Additionally, the qualitative methods allow for
more detailed questions to be asked about patient and clinician experience with
communicating about smoking cessation in the context of the LCS decision-making
discussion.
The data I examine provide unique access to patients who undergo an LCS
decision-making discussion for two reasons. First, these data are unique because it is the
largest prospective study of patients offered LCS to date. Second, I have unique access to
all aspects of the study, from study design to data collection to analysis, through my work
as a Research Associate at the VA Portland Health Care System (VAPORHCS). Findings
of this dissertation contribute to the existing literature about smoking cessation and
hardened smokers. Importantly, these findings will add to the knowledge base and
4

sociological theory about fundamental causes, unique populations (e.g., hardened
smokers), and patient-clinician communication.
Sample and Setting
We recruited patients from three sites: the VAPORHCS, Portland, OR; the
Minneapolis VA Medical Center, Minneapolis, MN; and Duke University Medical
Center, Durham, North Carolina. Participants were outpatients who were eligible for LCS
based on age, smoking history, and comorbid diseases. Clinical criteria based on the
National Lung Screening Trial (NLST) included: men and women who are current or
former smokers (within 15 years) aged 55 to 77 with ≥ 30 pack-years of smoking (NLST
Research Team et al. 2011). Additional clinical criteria included patients who were
asymptomatic in terms of lung cancer symptoms, not undergoing active treatment for
cancer, had no history of lung cancer, and were physically able to tolerate surgical
resection for lung cancer. In addition to these clinical criteria, we did have research
eligibility criteria. First, patients must have been offered the LDCT for LCS by a
provider. Patients could accept or decline the LDCT. Second, we excluded those with
severe dementia, severe, uncontrolled schizophrenia or other mental illness, and severe
hearing impairment. Finally, no exclusions were made based on race/ethnicity, but we
limited enrollees to English speakers, either as a primary or secondary language. The
research team did not verify clinical eligibility.
The majority of this study population are Veterans, but about one-third are not.
Since two of the sites that contribute most of the sample are VA hospitals, it is important
to discuss Veteran status. Veteran cohorts are different from the general population in
5

several key areas. For instance, Veterans are predominately male, more educated, and
have higher incomes than the general population. Importantly, however, users of VA
Hospitals like those included in our study, are generally poorer, older, less well educated,
less likely to be employed, and have more chronic health conditions than either the
general population or Veterans who do not use VA hospitals (Morgan 2005).
National smoking rates for Veterans have declined about 15% from 2010 to 2015;
however, Veterans are still more likely to be current smokers compared to the civilian
population (21.6% vs. 14%) (Department of Veterans Affairs, Veterans Health
Administration 2015; CDC 2019). Similarly, 42% of US adults and 74% of Veterans are
current or former cigarette smokers (Mariolis et al. 2006), indicating that Veterans are
less likely to successfully quit smoking. Despite the availability of smoking cessation
programs in the VA healthcare system, smoking remains “accepted, accommodated, and
promoted” during active military service (Smith et al. 2014). As a result, almost half
(49%) of military service members reported using nicotine in the past year (Department
of Defense 2013) and almost one-third started smoking after joining the military (Bray et
al. 2006). One previous study found VA Hospital users were actually more likely to have
ever smoked (McKinney et al. 1997). Veterans are important to include in this study
because of their higher smoking prevalence, and the fact that lung cancer
disproportionately affects Veterans. Veterans have a higher lung cancer incidence
(Harris, Hebert, and Wynder 1989) and mortality (Campling et al. 2005) than the general
population, making it important to include them in studies of smoking cessation.
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Importantly, although all Veterans in this study were enrolled in VA health care,
the LDCT was not paid for by this study for any participant. Veteran participants may
have had a small co-pay (no more than $50) for the scan, but non-Veterans either had
insurance or paid out of pocket. Because access to care has been shown to be associated
with various health outcomes (Andersen 1995; Hoffman and Paradise 2008), and because
Veterans may have better access to care, this study will incorporate site location in the
RQ1 and RQ2 analyses.
Hardened Smokers
Patients offered LCS are by definition at high-risk of developing lung cancer.
They are eligible based on age (55-77 years), smoking history (either currently smoking
or a >30 pack-year history), and comorbidities. This population can generally be
considered as “hardened” smokers (note that we recognize the pejorative nature of the
term “hardened smokers,” but to date there has been no other agreed-upon term).
Hardened smokers are individuals who smoke that are “less likely to be influenced by
cessation measures” (Ney et al. 1989), and have no intention to quit and/or find it very
difficult to quit (Docherty and McNeill 2012). Hardened smokers are also more likely to
be from disadvantaged backgrounds (Lund, Lund, and Kvaavik 2011). These individuals
are difficult to reach but are equally as important to target for smoking cessation.
Sometimes hardened smokers may have given up on cessation, but it is important to
remember that it is never too late to quit smoking and even quitting later in life has
significant health benefits (Peto et al. 2000).

7

Because this study is focused on hardened smokers, it provides a unique
opportunity to examine the potential for socioeconomic, sociodemographic, and
psychosocial factors to improve rates of smoking cessation in this population. In addition,
all patients in this study have an added benefit of a decision-making discussion to include
smoking, which may alter patients’ knowledge and desire to quit. Therefore, there may be
differences in smoking behavior changes compared to those not in LCS programs. It is
important to determine if traditional well-correlated socioeconomic, sociodemographic,
and psychosocial factors remain significant in this potentially different population.
Literature Review
Socioeconomic and Sociodemographic Variations in Smoking and Smoking Cessation
I considered several socioeconomic and sociodemographic factors in this study,
including educational attainment, employment status, income, racial/ethnic status, marital
status, age, gender, and study site location. Income, educational attainment, and
employment status are components of SES and are well-known correlates to smoking.
Components of SES are, “factors that involve a person’s relationships to other people”
(Link and Phelan 1995:81), mainly involving economic positions in society. SES is “a
key underlying factor” that influences health. Indeed, smokers that come from
socioeconomically disadvantaged backgrounds tend to have more smoking-related
illness. This is a result of their almost three-fold higher prevalence of smoking compared
with those in higher socioeconomic brackets (Drope et al. 2018). Formally, I expect that
those with lower educational attainment, who are not employed, and have lower income,
will be more likely to smoke.
8

Sociologists like Kawachi et al. (1997), Frohlich, Chabot, and Corin (2002), and
Williams (2003), have widely examined the importance of SES as a single measure and
separately, as being important correlates with health behaviors, like smoking. SES may
influence smoking cessation indirectly, however. For instance, those with lower
educational attainment are less likely to feel self-efficacy or control over their life. They
may lack in resources such as knowledge of health and problem-solving skills. Education
produces self-efficacy (Mirowsky and Ross 2003) since education is not something that
can be lost or eliminated with a downturn in the economy. Via self-efficacy, education
can help people “cope actively and flexibly, avoid problems, and prepare for those that
cannot be avoided” (Mirowsky and Ross 2015:299). For these reasons, those with lower
levels of educational attainment may experience more stress and be less likely to utilize
preventive healthy behaviors, leading them to have higher smoking rates (Ross and
Mirowsky 1999).
Additionally, education typically leads to higher status occupations, more money,
better health insurance, and higher quality health care (see below for discussion about
occupation). Interestingly, though, people with lower educational attainment tend to have
poorer health than those with higher educational attainment even with access to the same
quality of care (Robert Wood Johnson Foundation 2014). The association with poorer
health may be due to increased stress (as above) or because of health literacy
discrepancies (van der Heide et. al 2013). Prior research has shown that educational
attainment affects decisions about smoking, including the decision to start smoking and
the decision to quit smoking (de Walque 2007; Jürges, Reinhold, and Salm 2011). For
9

instance, 26.2% of males who smoked who did not graduate from high school were able
to quit smoking, while 57.6% of males who smoked who graduated from college were
able to quit smoking (de Walque 2007). Another study found that for people with at least
a high school education, regular smoking did not occur until 19-24 years of age,
compared with those who did not graduate from high school, who started regularly
smoking at 18 years of age or less (Pierce et al. 1991).
Occupation is difficult to measure. Occupation is an “ambiguous term,” making it
hard to categorize into analytic components since it can be defined in different ways
(Royeen 2002). Occupation and employment status can, however, provide a marker of
self-efficacy since those with presence of an occupation, or higher status occupations,
generally have greater autonomy and control over their circumstances. The Whitehall
studies showed that SES defined by occupation is strongly and inversely related to
mortality, a claim supported by several studies since (Marmot et al. 1991). Lower ranked
occupations, and having no occupation at all, can limit autonomy and self-efficacy.
Deficiencies in autonomy and self-efficacy can increase stress, which is linked with
negative health behaviors, like smoking.
In addition, occupational differences can expose individuals to differing
occupation-related lifestyle factors. There are deeply rooted psychosocial attitudes and
effects of occupation that seem to persist despite knowledge about the detrimental effects
of smoking (Sterling and Weinkam 1990). For instance, blue collar occupations have a
history of allowing smoking and individuals in these occupations continue to smoke at a
higher rate (41% of farm laborers vs 28% of managers). Similarly, a higher proportion of
10

professionals and those in higher status occupations who do smoke, are able to
successfully stop smoking compared with those in blue collar occupations (50% vs. 35%,
respectively) (Sterling and Weinkam 1978).
Similarly, individuals with higher incomes generally have higher-paying jobs and
people in these positions generally have a greater sense of autonomy and self-efficacy,
thereby leading to better health. Frohlich and colleagues (2002), for instance, explored
how aspects of social structures, like income, influence smoking and community norms
surrounding health behaviors. People in poverty when measured by income are more
likely to continue to smoke (i.e., not successfully quit), for instance. This holds for
Veterans and civilians (Golden et al. 2018; Marmot and Wilkinson 2006). Income
provides key resources like the ability to purchase health care and more nutritious foods
(Adler and Newman 2002), access safer housing, and have greater technological access.
Thus, people with higher incomes can garner health information more easily, utilize
preventive medicine appropriately, and avoid risks more successfully.
Several other studies show strong associations between SES and health. In fact,
“people in lower social class positions have higher rates of virtually every disease”
(Syme and Yen 2000). Shishehbor et al. (2006) found that people with lower SES also
had greater physical disability and higher all-cause mortality. Those with the lowest
income and least educational attainment are consistently less healthy than those in the
higher income and educational brackets (Braveman et al. 2010), in part due to lack of
resources like knowledge and life skills that are important for health. The infamous Black
Report out of the UK in 1980 (Bartley, Blane, and Smith 1998) exemplified that even
11

when using multiple measures of social position, the gradational association of SES with
mortality remained. The three main SES components discussed here each provide similar
resources to each other, which is why they are often seen as proxies for measures of SES
as a whole. I will look at each well-correlated component separately in order to describe
this sample population
I also examine racial/ethnic status, marital status, age, gender, and study site.
Some minority racial groups such as American Indian/Alaska Natives (Nollen 2019) are
more likely to smoke compared with other racial groups, although this is not consistent
across all minority groups. For instance, African Americans have been found to be three
times more likely to be light smokers vs. heavy smokers when compared with whites, and
the differences were not explained by other sociodemographic features (Kabat, Morabia,
and Wynder 2011). Further, whites typically initiate smoking earlier compared to
minorities (Kandel et al. 2004), although prevalence of smoking among white adults is
about the same as for African American adults. Also, research shows that African
American adults are less successful at smoking cessation compared to white adults (CDC
2020). The U.S. Department of Health and Human Services (1998) notes this may be due
to lower utilization of cessation treatments and less access to preventive health services.
Reasons for the effects of race on health behaviors, like smoking, are likely
multifactorial. Racial categories comprise differing socioeconomic, political,
occupational, and educational components that can each affect health differently
(Williams 1997). For example, different racial and ethnic groups have important power
and status differences, which can be illustrated by differences in SES. Williams (1997)
12

points out the three-fold higher rate of poverty for African Americans, Latinos, American
Indians, and many Asian subgroups compared with Whites. These SES differences lead
to disparities in health through multiple avenues, as discussed above. Of course, there is
also the history of racism in America, which “created a set of norms that required the
differential treatment (discrimination)” of minority groups (Williams 1997), leading to
unequal health care, education, occupations, etc.
Rates of smoking are also elevated among those who are unmarried. Married
individuals are less likely to smoke than those who are divorced/separated/widowed and
those who are single (12.5% vs. 18.1% vs. 13.9%, respectively) (CDC 2020; Vannimenus
2018). Marital status and its association with positive health outcomes have also been
found, such as decreased stress, better overall self-reported health (Lorenz et al. 2006;
Osler et al. 2008), and others (Umberson and Montez 2010). For men, especially,
marriage is associated with an increased probability of successful smoking cessation
(OR=1.69) (Broms et al. 2003).
One aspect of marriage that may improve health is the social support the dyad
provides. It has been well documented that the social support gleaned via the marriage
dyad improves health outcomes in areas such as lupus (Mazzoni and Cicognani 2011),
mental health (Tajvar et al. 2013), and diabetes (Strom and Egede 2012), to name a few.
The importance of social support for health outcomes has been documented in various
types of cancer (Banik et al. 2016; Carpenter et al. 2010; Ikeda et al. 2013; Kroenke et al.
2013; Luszczynska et al. 2013; Nausheen et al. 2009; Pinquart and Duberstein 2010) as
well. Clinical benefits of social support in cancer include mortality benefits, protection
13

against disease progression and incidence, and mitigation of mental health issues
(Carpenter et al. 2010; Ikeda et al. 2013; Kroenke et al. 2013; Nausheen et al. 2009;
Pinquart and Duberstein 2010).
Social support is important for both biological and behavioral reasons for health.
Some studies show that higher levels of social support equate to lower levels of certain
hormones that are deleterious to cancer cells. Also, having the social support provided by
a spouse affects behavior since the spouse can encourage treatment seeking or be a
motivator for positive health changes (Pinquart and Duberstein 2010), like quitting
smoking. There are four main types of supportive actions: emotional, instrumental,
informational, and appraisal. Emotional actions are often the most widely discussed. This
type of support includes showing empathy, sympathy, love, caring, and listening.
Instrumental support includes more functional aspects of support like taking patients to
appointments, as well as providing concrete supplies or materials to assist with practical
issues (Thoits 2010). Informational support is any advice or information that others can
provide to an individual. Often this type of support comes from health care providers.
Appraisal support is generally the least discussed and possibly the least commonly
measured, but it involves any assistance from others that may aid in self-esteem or selfevaluation (Heaney and Israel 2008). This type of support can also come from health care
providers. Social support often comes from a spouse, but of course clinicians may be an
important part of the circle of people providing social support for hardened smokers
offered LCS.

14

Between the ages of 25 and 64 current smoking rates are about the same, around
16%. Over the age of 64, however, it drops to 8.4% (CDC 2020). This could be due to the
historical use of targeted tobacco advertising to minors, or the influence on youth of role
models who use cigarettes (Steinberg and Delnevo 2013). Additionally, one study found
that among older smokers, heavier smokers who used equal to or more than 25 cigarettes
per day were the most likely to successfully quit smoking, whereas for younger smokers,
those who used less than 25 cigarettes per day were more likely to stop (Coambs, Li, and
Kozlowski 1992). This finding may relate to an increase in desire to quit as tobaccorelated and other health or financial effects produce a heavier burden during aging
(Steinberg and Delnevo 2013; Golden et al. 2020). I do not expect much variation in
smoking based on age since our population is within a rather narrow 55-75-year age
range.
Males have a higher smoking rate than females (15.6% vs 12.0%, respectively)
(CDC 2020) in the general population and generally have a higher smoking intensity
(McClure et al. 2020). Females have a worse quit rate though, where they are 31% less
likely to quit successfully compared to males (National Institute on Drug Abuse 2020). A
large, multi-national, retrospective study used a comparative risk framework to determine
the prevalence of smoking by sex and age (GBD 2015 Tobacco Collaborators 2017). This
study supported other findings that the general prevalence of smoking for women is less
than for men, but so were successful reductions in smoking. I would expect males to be
more likely to currently smoke based on the higher smoking rates and the population of
hardened smokers and Veterans being studied.
15

There is a rather large body of literature describing gender inequality and the
relationship with women’s smoking and changing gender roles, mostly centered around
popular culture’s portrayal of smoking. Cessation interventions are also often thought to
work the same across genders (Bottorff et al. 2014), or may only differ based on
biological factors, ignoring social gender-specific issues. This assumption is in contrast to
the evidence that quit rates differ significantly between men and women. Thus, it is
important to be aware of and document the differences between genders in the reasons
and theory behind their smoking behaviors in order to develop and implement effective
interventions.
All site locations selected for this study serve relatively large rural populations
also, who also have higher smoking rates compared to their urban counterparts (Atkins,
Kim, and Munson 2017; Robert, Doogan, and Kurti 2016). Reasons for the increased
smoking rates are likely related to differences in SES between rural and urban divisions,
however even among all income levels. For instance, Roberts et al. (2016) found that
people in rural areas still had higher rates of tobacco use compared to their urban
counterparts. Income differences though, do seem to have an additive effect on smoking
prevalence (Higgins et al. 2016). Reasons for increased smoking in rural populations
could be due to targeted marketing by tobacco companies or differences in education
(Roberts, Doogan, and Kurti 2016). Even though all sites in this study include large rural
populations in their catchment areas, patients from our Duke University site self-selected

16

for smoking cessation assistanceso I expect them to have more individuals who were able
to successfully quit smoking.
Certainly, specific subgroups of people are more likely to initiate and continue
smoking compared to others, and these differences are largely based on SES and
sociodemographic factors. Undoubtedly, there is evidence that the results of all studies
are showing an association of SES, sociodemographics, and health based on lack of
resources like reduced access to health behavior/cessation techniques or knowledge, lack
of motivation or control, reduced social capital, or chronic stress (Elo 2009; Thoits 2010;
Umberson, Crosnoe, and Reczek 2010).
Psychosocial Resources: Self-efficacy
House (2002) provides a comprehensive background on the emerging role of
psychosocial factors, like self-efficacy, in health. Interestingly, it was spurred by the 1964
Surgeon General’s report (U.S. Department of Health and Human Services 1964) on
smoking that identified psychosocial factors as being important in smoking and smokingrelated diseases. House noted that negative psychosocial factors like stress, anxiety, low
self-esteem , or low self-efficacy are chronic, can lead to negative health behaviors, like
smoking (House 2002). Self-efficacy emerged as one of the most significant psychosocial
factors involved in smoking cessation (Strecher 1986), providing a reliable measure of
abstinence from smoking (Gwaltney et al. 2009) and successful cessation (DiClemente,
Prochaska, and Gibertini 1985).
Self-efficacy refers to “beliefs in one’s capabilities to organize and execute the
courses of action required to produce given attainments” (Bandura 1997). That is, self17

efficacy is a mechanism whereby a person senses control (Bandura 1997), or mastery,
over their circumstances and health. Self-efficacy sustains confidence and is often
associated with lower reports of anxiety and depression (Mirowsky and Ross 2003). Selfefficacy is part of a positive self-experience contributing to health and well-being. The
sense of control or mastery is related to the likelihood of developing and dying of chronic
disease. Environment, social supports, and other psychosocial aspects of one’s life
influence levels of self-efficacy (Marmot and Wilkinson 2006) and may change over
time.
Psychosocial Resources: Communication
Patient-clinician communication is widely regarded as a key component of high
quality care that can improve patient-centered outcomes (IOM 2013; Mead and Bower
2000; Simpson et al. 1991; Weiland et al. 2012), like improved health behaviors. The
patient-centered communication model posited by Street et al. (2009), identifies five
domains of health communication. The patient-centered communication domains include:
information exchange (sharing information about risks, benefits, etc.); patient as person
(consideration of patients’ feelings, preferences, and values); sharing power and
responsibility (shared decision-making); therapeutic alliance (the need for patient and
clinician to be “on the same page”); and clinician as person (taking the clinicians’
limitations and knowledge into consideration) (Figure 1). Since shared decision-making
is mandated as part of the LCS decision-making discussion and is a domain of highquality patient-centered communication, (Mead and Bower 2000), I examine the presence
of communication to determine the association with smoking cessation.
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Figure 1. Patient-Centered Communication Model

In addition, a 2008 report published by the Agency for Healthcare Research and
Quality (AHRQ) recommends that “every individual entering a health care setting”
should have their smoking status assessed and clinicians should advise their patients who
smoke to quit (2008 PHS Guideline Update Panel, Liaisons, and Staff 2008). The AHRQ
recommendation was based on a meta-analysis showing evidence that even brief advice
given by a physician (Lancaster and Stead 2004), or other clinicians (Bao, Duan, and Fox
2006), can significantly increase cessation rates. One central method of communicating
about smoking cessation is through use of the 5A’s. The 5A’s are Ask, Advise, Assess,
Assist, and Arrange, and should be used at every clinical encounter. “Ask” refers to
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identifying a patient’s smoking status (never, former, or current); “Advise” refers to
encouraging cessation in a “clear, strong, and personalized manner”; “Assess” refers to
determining the patient’s willingness to quit; “Assist” refers to offering tailored smoking
cessation strategies, such as referrals to counseling, medications, or other resources; and
“Arrange” refers to scheduling follow-up to assess treatment outcomes and provide
ongoing care (Agency for Healthcare Research and Quality 2012). The US Department of
Veterans Affairs and other medical systems have adopted use of the 5A’s via guidelines
put forth by the US Public Health Service (The Clinical Practice Guideline Treating
Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff 2008). While the
LCS decision-making discussion seems an opportune time to utilize techniques like the
5A’s to communicate about smoking behaviors, it is unknown how or if they are applied
in the LCS context.
Communication, therefore, has significance in eliciting successful smoking
cessation, and is explored herein using quantitative surveys. Additionally, I explore the
nuances of this communication qualitatively.
Lung Cancer Screening
In 2020, approximately 228,820 people in the U.S. are expected to be diagnosed
with lung cancer (American Cancer Society 2020), and this number is likely to increase
with further emerging evidence recommending LCS (Bach et al. 2012; Humphrey et al.
2013; Jaklitsch et al. 2012; Jensen et al. 2015; Moyer 2014). Large numbers of people at
increased risk of lung cancer. Veterans, in particular, have a disproportionately higher
lung cancer incidence (Harris, Hebert, and Wynder 1989) and mortality (Campling et al.
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2005) than the general population. VA facilities diagnose about 7,700 Veterans every
year with lung cancer and almost 900,000 Veterans are at risk (Sprey 2020). This is likely
attributable to environmental exposures, but maybe more importantly, prior policies
enabling the Department of Defense to supply cigarettes to troops and include them in
basic rations until 1975. Though this policy is no longer in place, 30% of Veterans
continue to smoke, twice the amount of the general population (Food and Drug
Administration 2020).
The goal of LCS, like any screening, is to detect disease early in people who do
not have any symptoms of disease. LCS is now recommended by several organizations
such as the United States Preventive Services Task Force (U.S. Preventive Services 2004;
Moyer 2014), the American Cancer Society (Wender et al. 2013), and others (Bach et al.
2012; Jaklitsch et al. 2012; Samet et al. 2012; Wood 2015). It is estimated that up to 7
million US adults may be eligible for screening (NLST Research Team [NLST] et al.
2011). These determinations were made on the basis of the largest clinical trial in
American history, the NLST. The NLST showed that using the LDCT (compared to a
normal x-ray) could improve lung cancer and overall mortality by 20% and 7%,
respectively, in the eligible population (NLST Research Team et al. 2011).
While receipt of the LDCT has not been shown to impact smoking cessation
(Slatore et al. 2014), high quality communication has been shown to impact cessation
(Bailey et al. 2018; Bao, Duan, and Fox 2006; Lancaster and Stead 2004; LindsonHawley, Thompson, and Begh 2015).This may be especially true within an LCS
decision-making discussion given that communication may be improved within shared
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decision-making contexts. Notably, all patients in this sample received a decision-making
discussion. For the purposes of this dissertation, I utilize LCS as the context in which the
decision-making discussion and smoking conversations are conducted.
The LCS Decision-Making Discussion
Importantly, the United States Preventive Services Task Force gave LCS a grade
B recommendation, meaning they recommend the intervention and require private
insurers to extend coverage for this screening. The Centers for Medicare and Medicaid
Services (CMS) has also agreed to pay for LCS (Jensen et al. 2015). These
recommendations, however, came with conditions (Jensen et al. 2015). For instance,
insurers require a decision-making discussion to occur prior to receipt of the LDCT; the
first time such a requirement has been made.
To facilitate decision-making and communication for LCS, a qualified
practitioner must use a decision aid recognized by a national professional medical
organization. In this study, clinicians from the two VA sites typically used the VAproduced decision aid (Appendix A), while at Duke University they used a decision aid
created by the Agency for Healthcare Research and Quality (AHRQ) (Appendix B).
Within the decision-making discussion, there is also a requirement to provide smoking
cessation counseling and provision of cessation services as appropriate, since discussions
of LCS often address current and past smoking behaviors. It unknown though, if the
decision-making discussion improves rates or opinions of smoking cessation through
communication.
Methods
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Overview
This dissertation uses existing data from a longitudinal, observational, mixedmethods cohort study of patients offered LCS in three institutions: VAPORHCS,
Portland, OR; Minneapolis VA Medical Center, Minneapolis, MN; and Duke University
Medical Center, Durham, NC. We strategically chose these sites to include patients with
demographic diversity across economic, racial, and urban/rural domains. We also
included clinicians who discussed LCS with patients to obtain the clinician perspective.
The study Principal Investigator is Christopher Slatore, MD, MS at VAPORHCS, the
coordinating site.
LCS may uniquely influence patient-centered outcomes given the distress about
lung cancer since it has a high mortality compared to other cancers. Patient-centered
outcomes from screening trials have been described (Harris et al. 2014; Humphrey et al.
2013) but many questions regarding the occurrence and magnitude of the expected risks
and benefits, such as continued smoking, in routine care settings remain.
Lung Cancer Screening as a Process
LCS is usually initiated by clinicians asking eligible patients if they are interested.
Since LCS is still in the beginning stages, and since it was not widely publicized at the
time of this study, patients were unlikely to ask for LCS themselves. Upon confirmation
of patient interest, the patient and clinician are required to undergo the decision-making
discussion, which ends in the patient deciding either to accept, decline, or postpone the
LDCT. The LDCT in both VA sites was generally performed within one to two weeks of
the decision-making discussion, however patients were able to schedule the scan for
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whenever was convenient for them. , The VAPORHCS began walk-in appointments for
the LDCT toward the end of enrollment so patients could come in any time MondaySaturday to obtain their scan, which made LDCT timing more variable. At Duke
University, the LDCT was usually performed approximately one month after the
decision-making discussion, however this was variable depending on patient and hospital
imaging department scheduling.
Study Eligibility
We prospectively recruited subjects from March 2016-April 2019; follow-up
visits concluded in May 2020. We recruited outpatients eligible for LCS based on age,
smoking history, and comorbid diseases. Clinical criteria based on the NLST included:
men and women who are current or former smokers (within 15 years) aged 55 to 77 with
≥ 30 pack-years of smoking (NLST Research Team et al. 2011). Additional clinical
criteria included patients who were asymptomatic in terms of lung cancer symptoms, not
undergoing active treatment for cancer, had no history of lung cancer, and were
physically able to tolerate surgical resection for lung cancer. In addition to these clinical
criteria, patients must have been offered LCS by a provider. Patients could accept or
decline the LDCT. Our research criteria excluded those with severe dementia, severe,
uncontrolled schizophrenia or other mental illness, and severe hearing impairment. No
exclusions were made based on race/ethnicity, but we limited enrollees to English
speakers, either as a primary or secondary language. The research team did not verify
clinical eligibility. We utilized IRB-approved research methods at each site
(VAPORHCS #3482; Minneapolis VA #4645-B; Duke #Pro00073394). Of note, patients
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without personal phones were still eligible and we coordinated study visits with times
they were seen in clinic. The complete protocol has been published previously (Miranda
et al. 2017) (Appendix C).
Research Question 1 Overview
RQ1 is a quantitative study designed to describe and compare patients offered
LCS who formerly smoked and those who currently smoked at the time of the baseline
survey. We used convenience sampling to obtain our cohort. I identified these patients by
examining the answer to the question, “How would you describe your cigarette
smoking?” This question can be found in Appendix D Section 11 #1.
Timing and Setting
RQ1 utilized quantitative surveys conducted before the LDCT but after the
decision-making discussion with the clinician for patients who accepted the LDCT. For
those who declined the LDCT, we conducted surveys after the decision-making
discussion. Trained research assistants (RAs) conducted the quantitative surveys with
patients primarily over the phone, or in person. The RA at each institution conducted
their own patients’ surveys.
Study termination occurred for the following reasons: 1) patient declined further
participation, 2) lung cancer was diagnosed, or 3) follow-up was completed. If patients
were lost to follow-up, attempted contacts were made via telephone, letter, and contact of
the patient’s primary care provider. If the patient was diagnosed with lung cancer, she/he
was asked to complete a follow-up survey after diagnosis which focused on concerns
about the lung cancer evaluation process. At the end of the study, 497 patients were
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consented total; 414 enrolled for RQ1 and RQ2, and 51 patients and 24 clinicians for
RQ3. Five of the 414 enrolled were diagnosed with lung cancer.
Data
At the initial study visit, we collected data on the primary outcome, smoking
behaviors, as well as secondary outcomes not utilized in this dissertation. We also
collected demographic, health history, and other electronic health record data. The RA at
each site collected all survey and electronic health record data on paper forms. These
forms were then shipped to the lead study RA from Portland, the coordinating site, who
compiled all the surveys and inputted that, along with the survey data from Portland
patients, into a VA REDCap database. REDCap is “a secure web application for building
and managing online surveys and databases,” that we were able to modify to fit the study
needs (Harris et al. 2009).
Descriptive Variables
For RQ1, the primary descriptive variables were educational attainment,
employment status, income, race/ethnicity, marital status, age, gender, and study site
location. All variables were from the baseline survey. The exact questions asked for the
descriptive variables can be found in Appendix D Section 1 Questions #1-6 and 8. I
grouped demographic variables accordingly based on frequency during the initial data
analysis phase.
Smoking status is defined by a self-report answer to the question, “How would
you describe your cigarette smoking?” Response options include: Never smoked (less
than 100 cigarettes in your lifetime); Past smoker (quit over 7 days ago); and Current
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smoker (any smoking, even a puff, within the past 7 days) (Appendix D Section 11 #1).
This defines the 7-day point prevalence abstinence, a commonly used and well-validated
measure of successful tobacco cessation (Velicer and Prochaska 2004). We did not
measure biochemical evidence of smoking. This variable was dichotomized into former
vs current smoking. Each descriptive variable was used to describe and compare those
who formerly smoked and those who currently smoked.
Table 1. Research Question 1 Variables

Descriptive Variables

Dependent Variable

Income

Smoking status (dichotomized)

Educational attainment
Employment status
Race/ethnicity
Marital status
Age
Gender
Study site location

RQ1 Analysis
After describing the cohort, I performed a bivariate analysis to explore the
relationship between the variables (Sayad 2018) in the two smoking groups.
Research Question 2 Overview
RQ2 is a longitudinal quantitative study of patients designed to examine if
communication influences smoking status. We used convenience sampling to obtain the
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cohort, as was used in RQ1. For this research question I only included patients who
currently smoked at baseline. I identified these patients by examining the answer to the
question, “How would you describe your cigarette smoking?” This question can be found
in Appendix D Section 11 #1.
Data
I measured presence of communication based on the answer to one question from
a survey instrument based on work by Borrelli (Borrelli et al. 2001; Borrelli, Lee, and
Novak 2008). The question asks, “Did the person who talked with you most about
screening discuss quitting smoking with you?” The response options include: No, Yes,
and Could Not Recall (Appendix D Section 12 #1). Two previous studies by Borrelli
used this instrument to determine that attitudes and beliefs about smoking are
significantly associated with counseling behaviors for nurses providing information about
smoking cessation (Borrelli et al. 2001), and to compare communication quality of nurses
providing cessation (Borrelli, Lee, and Novak 2008). The entire instrument is 16
questions, however there is not a summary index available, only individual questions are
used.
For RQ2, smoking status at one-year follow-up is the dependent variable, defined
identically as in Aim 1. Table 2 below lists the covariates. Study site location is either
VAPORHCS, VA Minneapolis, or Duke University. Nicotine dependence was measured
using one question from the Fagerström Test for Cigarette/Nicotine Dependence
(Heatherton 1991): “How soon after you wake up do you smoke your first cigarette?”
This question was found to be most predictive of nicotine dependence (Heatherton 1991).
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Table 2. Research Question 2 Variables
Independent

Dependent Variable

Covariates

Smoking status at 1-year follow-up
(dichotomized)

Study Site
Location

Variable
Presence of
Communication

Nicotine
Dependence
Analysis
For RQ2, I first summarized the descriptive data for demographic variables and
the scores on self-report measures for all participants. Next, I performed bivariate
statistics to determine differences between the two groups. I then utilized a logistic
regression analysis to determine the association of presence of patient-clinician
communication with smoking status at one-year follow-up. I selected logistic regression
because the dependent variable is binary. The primary models were constructed
parsimoniously, excluding variables that were not confounders if the marginal effect was
not more than 10%. I also performed a sensitivity analysis separating the Could Not
Recall and No discussion responses into two variables. I used STATA v.16 for analysis,
employing p<0.05 criterion for statistical significance.
Research Question 3 Overview
RQ3 is a qualitative study that explores how patients and clinicians communicate
about smoking within the LCS decision-making discussion. This study provides nuance
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and explanation for the findings in Research Questions 1 and 2, as well as provides
evidence about the use of the 5A’s and their use in LCS programs.
Sampling
For RQ3, we used purposive sampling to strive for maximum variation in patient
characteristics and response to the evaluative process. We aimed to select approximately
16 patients from each site until we reached 48: 36 patients who opted for screening and
12 who did not. We conservatively anticipated the rate of positive results after the initial
CT would be 25% so we expected 5 patients in this group. Given our hypothesis that this
group may be at particular risk of distress, we also over-sampled 12 extra patients known
to have positive results. These 12 patients were recruited in year 2, after the initial
subjects were enrolled. For RQ3, we consented 65 patients total and enrolled 51.
Twenty-four clinicians were consented and enrolled for qualitative interviews
only. We recruited clinicians based on identification by the local site PIs as being
involved in the LCS process. We initially recruited clinicians via an email invitation
letter.
Timing and Setting
The qualitative patient interviews utilized herein were conducted before the
LDCT but after the decision-making discussion for those who accepted the LDCT. For
those who declined the LDCT, the interviews were conducted within 4 weeks of the
decision-making discussion. I conducted the qualitative interviews (occasionally with the
PI) over the phone, or in person if possible. If the patient was seen in person, the
interview was conducted in a private room at the subject’s preferred institution. There
30

was one interview for clinicians that was not time dependent. We conducted clinician
interviews over the phone, and all were conducted by me in a private office space.
Data
Each patient baseline interview lasted approximately 45 minutes. Provider
interviews lasted 45-60 minutes. We utilized semi-structured, in-depth qualitative
interviews using an interview guide that allowed for other themes and questions to
emerge. We digitally recorded and transcribed interviews, taking care to remove any
identifiers during transcription. Further, we coded transcripts to protect anonymity.
Patients described their experiences with LCS, focusing on communication processes, as
well as discussed thoughts about smoking in relation to screening and barriers to smoking
cessation. Clinician interviews focused on communication regarding smoking, the
perceived importance of discussing smoking and screening together, and perceived
patient challenges to cessation (Appendix E). I aimed to identify facilitators and barriers
to smoking cessation (including use of communication and patient factors, like the 5A’s
and self-efficacy).
Analysis
We used a conventional content analysis approach to determine nuances about
communication regarding smoking during LCS decision-making discussions. I first read
each completed transcript closely to become familiar with the content. Next, I reviewed
two transcripts to develop a preliminary codebook, although some preliminary codes
were identified previously as key concepts based on the interview guide. A second
reviewer reviewed the same two transcripts and reviewed the coding and codebook with
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me. I then independently coded an additional three transcripts and discussed with the
second reviewer. As a group with the PI, we met to discuss and refine the codebook,
review, and re-code transcripts as needed until all were coded. If other themes arose from
the data, I added them to the coding scheme and re-coded any transcripts coded
previously. Lastly, I reviewed the data again to identify further codes, create new memos,
and reconcile discrepancies. Throughout this process I evaluated any overlapping coding
or uncoded text to verify appropriateness.
I first created main, or ‘parent,’ codes; some parent codes included several, more
specific, ‘child’ codes. We developed initial and integrative memos throughout in order
to capture thoughts or analytic ideas, which aided in the final interpretation of the data
through identifying patterns and variations in the transcripts. We used Atlas.ti v.7.1.7 for
organizing and coding transcripts.
Hypotheses and Future Studies
For RQ1, I expected to find that individuals of lower income, less education,
unemployment, of minority racial/ethnic status, not married, female gender, and those at
the VAPORHCS or Minneapolis VA would be less likely to report successful smoking
cessation compared to those who had higher income, more education, employment, were
non-minorities, were married, were male, and were at Duke University (Gorini et al.
2018; Jha et al. 2006; Royal College of Physicians 2016). For RQ2, I expected that
individuals reporting presence of communication about smoking with their clinician
would be more likely to report successful smoking cessation at the end of the study
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period. For RQ3, I expected to find out more details about how patients and clinicians
communicate about smoking.
Future studies can be guided by these data. For instance, health promotion
literature indicates that targeting specific subgroups of people with health-related
messages may work better than large-scale canvassing (Latimer, Salovey, and Rothman
2007). Therefore, talking to specific groups of patients who smoke may influence them
more than other types of cessation advertising or recommendations. The knowledge of
the addition of the LCS decision-making discussion being a potential motivator to
influence patients to improve their smoking behaviors would be clinically important. By
targeting those offered LCS and using cessation-related messages that are tailored to their
specific subgroup, we may be able to help certain populations successfully quit smoking
in future studies designed to develop interventions.
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Abstract
Objective: Lung cancer screening (LCS) using low-dose computed tomography (LDCT)
is now covered by private insurers as well as the Centers for Medicare and Medicaid
Services. LCS-eligible patients can generally be considered as “hardened” smokers who
have no intention to quit or find it extremely difficult to quit. Hardened smokers have not
been described. This study aims to describe the characteristics of hardened smokers and
to determine which important socioeconomic and sociodemographic factors are
associated with former or active smoking in this population.
Methods: We surveyed patients eligible for LCS from three medical centers in the US
with established LCS programs. We enrolled patients before the LDCT for those who
accepted the LDCT, and within three weeks for those who did not accept the LDCT. We
summarized the descriptive socioeconomic and sociodemographic data for all
participants and conducted bivariate analyses using Pearson chi-squared tests to compare
the current and former smokers.
Results: Our analytic sample consisted of 404 participants: 229 (57%) participants who
currently smoked cigarettes and 175 (43%) participants who reported formerly smoking
cigarettes at baseline. The majority of the subjects were male (87%), had some college or
vocational work (46%), were not employed (76%), with 25% making less than $20,000
per year. Our sample was largely non-Hispanic white (85%) and married (47%). Current
and former smokers were similar on several measures. We observed significant
differences in income: current smokers reported incomes of less than $20,000 per year
with much greater frequency (31%) compared to former smokers (16%). We also
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observed significant race differences as a larger percentage of former smokers were nonHispanic white (89%) compared to current smokers (81%). In addition, we found that
former smokers were more likely to report male gender (93% vs 83%).
Conclusion: Patients offered LCS may be different compared to patients in other settings
where socioeconomic and sociodemographic factors seem to play more of a role in
smoking behaviors. Smoking cessation programs could tailor their approach to patients
offered LCS who may have other individual- or system- level characteristics that
influence the association between socioeconomic and sociodemographic factors, smoking
status, and smoking cessation.
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Introduction
The United States Preventive Services Task Force recommends lung cancer
screening (LCS) using low-dose computed tomography (LDCT) and has mandated its
coverage by private insurers; the Centers for Medicare and Medicaid Services (CMS) has
also agreed to pay for LCS (Jensen 2015). Patients offered LCS using LDCT are by
definition at high-risk of developing lung cancer and can be considered “hardened”
smokers. For our purposes, hardened smokers are identified based on LCS eligibility
criteria, i.e. age (55-77 years), smoking history (either currently smoking or a >30 packyear history), and comorbidities. Importantly, those who have successfully quit smoking,
but were hardened smokers in the recent past, meet eligibility criteria for LCS.
Hardened smokers are those who are “less likely to be influenced by cessation
measures” (Ney 1989) and have no intention to quit and/or find it very difficult to quit
(Docherty and McNeill 2012). Hardened smokers are more likely to be from
disadvantaged socioeconomic backgrounds (Lund et al. 2011), which further increases
likelihood of smoking as well as smoking-related illness (Drope et al. 2018; Marmot and
Wilkinson 2006; U.S. Department of Health and Human Services 2014). These smokers
are difficult to reach but are still important to target for smoking cessation. Notably,
characteristics of hardened smokers have not been well-described in prior literature.
Accordingly, this study aims to describe the characteristics of hardened smokers
and to determine which socioeconomic and sociodemographic factors are associated with
former or active smoking in this population. Indeed, it remains important to identify
people for smoking cessation as quitting at any stage, including later in life, has
61

significant health benefits (Peto 2000). By describing factors associated with a hardened
smokers’ ability to quit smoking, we add to the scant knowledge about hardened smokers
and more closely define this population.
We focus on hardened smokers offered LCS recruited from Veterans Affairs
(VA) and non-VA (Duke University) facilities to answer the following questions: 1)
What are the socioeconomic and sociodemographic factors of hardened smokers? 2) Are
there differences in traditionally well-correlated socioeconomic and sociodemographic
factors between active and former hardened smokers?
Socioeconomic status (SES) is “a key underlying factor” that influences numerous
health outcomes (Link and Phelan 1995). Accordingly, a large body of literature has
established the importance of SES in predicting smoking initiation, smoking cessation
(Nagelhout 2012; Federico et al 2007; Pierce et al 1989), and smoking-related illness
(Campaign for Tobacco-Free Kids 2015; Singh 2011; Clegg 2009). For example,
individuals of lower SES are more likely to smoke, and among smokers, those with lower
SES are less likely to quit. As a result, the prevalence of smoking-related illness is almost
three times higher among socially disadvantaged individuals, compared to their
counterparts (Drope 2018). Thus, we incorporate factors of SES: income, educational
attainment, and employment status. Each factor, separately and combined, is a
traditionally well-known correlate to smoking. Formally, those with lower incomes,
educational attainment, and who are not employed are more likely to smoke.
Smoking cessation has also been linked to several sociodemographic factors
including race/ethnicity, marital status, age, gender, and location. Analyses have shown
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that non-Hispanic white individuals generally smoke at a higher rate than some minority
populations, e.g. non-Hispanic blacks, Hispanics, and Asians, but they smoke less than
American Indian/Alaska Natives (CDC 2020). However, non-Hispanic whites are more
likely to use cessation treatments and successfully quit smoking compared with Hispanics
(Babb 2020). Interestingly, non-Hispanic blacks are actually more likely to attempt to
quit smoking but are less likely to successfully quit (CDC 2020).
Married individuals are also more likely to successfully quit smoking (CDC 2020;
Vannimenus 2018) in many populations, with indicators that this may be a consistent
trend across groups. Between the ages of 25 and 64, current smoking rates are about the
same, around 16%. Over the age of 64, however, it drops to 8.4% (CDC 2020). This
finding may relate to an increase in desire to quit as tobacco-related and other health or
financial effects produce a heavier burden during aging (Steinberg and Delnevo 2013;
Golden et al. 2020). Males have a higher smoking rate than females (15.6% vs 12.0%,
respectively) (CDC 2020) in the general population and generally have a higher smoking
intensity (McClure et al. 2020). People from rural areas not only have higher smoking
rates (Roberts 2016), but also higher disease incidence per capita and lower survival,
despite access to diagnostic services (Atkins 2017). They also have less treatments
available for cessation, making it harder for them to quit successfully (Butler 2012). It is
important to determine if these previously correlated factors are similarly reflected
among hardened smokers.
SES, race, marital status, age, gender, and location, among others, have all been
documented as important correlates to health under the umbrella of fundamental causes.
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A fundamental cause is a social factor interconnected with disease, and social and
economic resources (Link and Phelan 1995). Further, theory around fundamental causes
requires an enduring, persistent relationship between the cause and health even after
conditions associated with the cause are eliminated by control. The mechanisms are
likely multifactorial. For preventable diseases though, like lung cancer, there are higher
SES-mortality gradients compared to non-preventable diseases, and this link is based on
mechanisms like increased control, knowledge, demand, lifestyle, or psychosocial
resources (Ross and Wu 1995; Phelan et al. 2004; Dahl, Hofoss, and Elstad. 2007; Song
and Byeon 2000).
This evidence supports the fundamental cause theory because it shows that there
must be qualities inherent in the social concept of SES that signifies some advantage in
avoiding preventable disease. There is something about SES and the effect on mortality
that is not explained by behavioral, environmental, psychological, or other physiologic
mechanisms. If the fundamental cause theory were incorrect and public health
epidemiology was on the right track in focusing on proximal mechanisms for health and
disease, then preventable and non-preventable diseases would all equate to similar
outcomes for people of all SES levels since it would not matter if some had greater
resources to prevent disease. This is not the case and has been shown in several diseases
such as breast cancer (Krieger et al. 2003) and lung cancer (Glied and Llleras-Muney
2008). It is important to study and document the associations of fundamental causes like
those listed here with health in order to add evidence to theory and the knowledgebase
about unknown populations, like hardened smokers.
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This study provides a unique opportunity to better understand hardened smokers
as it offers an assessment of the socioeconomic and sociodemographic factors of those
who were able to quit compared to those who were currently smoking. It is important to
determine if traditionally well-correlated socioeconomic and sociodemographic factors
remain significant across this potentially different population. Further, this is generally
considered a hard to reach population, and they have historically been left out of
cessation trials (Zbikowski 2012; Docherty 2012). Thus, little is known about their
characteristics, and this analysis contributes to foundational knowledge about hardened
smokers.
Methods
Setting
We surveyed patients eligible for LCS from three medical centers in the US with
established LCS programs; VA Portland Health Care System (VAPORHCS), Portland,
OR; Minneapolis VA Medical Center, Minneapolis, MN; and Duke University Medical
Center, Durham, NC.
Sample
We enrolled 414 patients who were eligible for LCS based on research referrals
from clinicians, who verified clinical criteria, including smoking history, age, etc.,
(Miranda et al. 2017) not further confirmed by the research team. The research-specific
criteria were that patients must have been offered LCS by a clinician. Also, we excluded
those with severe dementia, severe, uncontrolled schizophrenia or other mental illness,
and severe hearing impairment. No exclusions were made based on race/ethnicity, but we
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limited enrollees to English speakers, either as a primary or secondary language. We
included patients regardless of whether they agreed or declined to undergo the LDCT.
We enrolled patients before the LDCT for those who accepted the LDCT, and within
three weeks for those who did not accept the LDCT. The study was IRB-approved at each
participating site (VAPORHCS #3482; Minneapolis VA #4645-B; Duke #Pro00073394).
Data and variable definition
We conducted quantitative surveys to establish baseline characteristics of patients
before the LDCT but after the decision-making discussion with the provider. For those
who declined screening, we conducted surveys within 4 weeks of the decision-making
discussion.
We defined smoking status by a self-report answer to the question, “How would
you describe your cigarette smoking?”. Response options include: Never smoked (less
than 100 cigarettes in your lifetime); Past smoker (quit over 7 days ago); and Current
smoker (any smoking, even a puff, within the past 7 days) (Appendix D). This defines the
7-day point prevalence abstinence, a commonly used and well-validated measure of
successful tobacco cessation (Velicer and Prochaska 2004). We did not measure
biochemical evidence of smoking.
The primary descriptive variables are educational attainment, employment status,
and income. We collected these data by asking participants, “What is the highest level or
grade of school you have completed?”; “Are you currently employed?”; and “What is the
average total yearly income for your household?” We categorized educational attainment
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into high school or less, some college/vocational work, and college graduate or more.
These categories were based frequencies. Employment was dichotomized into employed
vs not employed, based on previous literature showing the importance of employment.
Income was measured by total household income and then split into 5 categories for
analysis: less than $20,000; $20-39,999; $40-59,999; $60-79,999; and greater than or
equal to $80,000. These categories were chosen based on current poverty levels (U.S.
Department of Health and Human Services. Office of the Assistant Secretary for
Planning and Evaluation. 2017). Additional variables included in the study are:
race/ethnicity, based on US Census questions (United States Census Bureau 2018) and
categorized into non-Hispanic white, all others, and refused, based on frequencies;
marital status categorized into married, divorced/separated/widowed, never married, and
refused, based on past literature showing health differences between categories (CDC
2020); age; self-reported gender, with responses being male or female; and site location.
All questions with the possible responses are shown in Appendix A.
Analysis
Prior to conducting analyses, we checked the data for completeness and accuracy
(STATA v.16). For this analysis we excluded those with missing values for income
(n=1), educational attainment (n=8), employment status (n=4), or smoking status (n=2)
for a final analytic sample of 404 participants. We summarize the descriptive data for
demographic variables and self-report measures for all participants in Table 1. We
conducted bivariate analyses using Pearson chi-squared tests to compare socioeconomic
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and sociodemographic factors of participants who reported formerly smoking cigarettes
or currently smoked cigarettes at baseline (Table 2).
Results
Descriptive findings
Our sample consisted of 404 total participants: 229 (57%) participants who
currently smoked cigarettes and 175 (43%) participants who reported formerly smoking
cigarettes at baseline. Slightly more than half (51%) were treated at the VAPORHCS,
32% at the VA Minneapolis, and 17% at Duke University, with an average age of 65. The
majority of the subjects were male (87%), had some college or vocational work (46%),
and were not employed (76%). Income categories were relatively even, with 25% making
less than $20,000 per year. Our sample was largely non-Hispanic white (85%) and
married (47%) (Table 1).
Table 2 shows descriptive statistics of our sample stratified by smoking status.
Current and former smokers were similar on several measures. For example, both current
and former smokers most commonly reported some college or vocational work (45% vs
47%, respectively) and the majority were not employed (75% and 78%, respectively).
Former smokers were slightly older (66 years) versus current smokers who were an
average age of 64 years old, but this difference was not statistically significant. However,
differences were observed across several measures. We did observe significant
differences (p<0.05) in income as current smokers reported incomes of less than $20,000
per year with much greater frequency (31%) compared to former smokers (16%). We
also observed significant race differences as a larger percentage of former smokers were
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non-Hispanic white (89%) compared to current smokers (81%) (p<0.05). In addition, we
found that former smokers were more likely to report male gender (93% vs 83%)
(p<0.005). Other differences, though non-significant were also observed: a greater
percentage of former smokers were married (51%) compared to current smokers (44%).
Discussion
We had the opportunity to describe a sample of generally hard to reach smokers.
Our results provide a description of hardened smokers’ characteristics focusing on
important socioeconomic and sociodemographic factors to add to the knowledge base
about this population. We determined which factors were associated with former or
active smoking. Consistent with previous findings, we found that income was
significantly lower for participants who currently smoked at baseline, males were less
likely to currently smoke, and non-Hispanic whites were less likely to currently smoke
(Drope 2018).
Our finding that income was significantly lower for participants who currently
smoked supports prior research documenting the importance of income on health. Other
studies have shown that those who are in poverty when measured by income are more
likely to continue to smoke (i.e., not successfully quit). Our findings suggest that the link
with poverty and continuation of smoking holds for Veterans and civilians (Golden 2018;
Marmot and Wilkinson 2006). A number of mechanisms may account for the association
between income and current smoking. For example, income affects health through both
direct and indirect pathways. Income can impact the ability toaccess health care and
health information more easily and higher income can allow for utilization of preventive
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medicine more appropriately (Frolich et al 2002). Those with higher incomes generally
have higher-paying jobs and people in these positions generally have a greater sense of
autonomy and self-efficacy, thereby leading to better health. The groups with the largest
decreases in ability to quit smoking have been those in the highest income brackets
(Drope 2018).
Educational attainment and employment status differences were not observed for
current versus former smokers. This is somewhat unexpected as a number of studies have
established the importance of these factors in predicting successful smoking cessation
(Nagelhout 2012; Pierce 1989). However, given the relatively older age of this sample
(recruitment targeted those 55 and older) and retirement status of this group, it is likely
that these factors are less relevant with respect to smoking behavior. It is also possible
that since our sample had been smoking for many years prior to being offered LCS and
our survey, the effects of these characteristics had already run their course. Other
characteristics may have become more prominent for influencing smoking status, such as
more graphic warning labels as deterrents (Azagba and Sharaf 2013; Shang et al 2017),
fear of withdrawal symptoms, or continued desire of stress reduction (Baker et al 2004).
The role of educational attainment and employment in predicting smoking behaviors in
hardened smokers should be investigated more closely.
As expected, we found that non-Hispanic whites were less likely to currently
smoke at baseline. Some racial/ethnic groups are more likely to currently smoke
compared to non-Hispanic whites, for example, American Indians or Alaska Natives.
Individuals who report as Asian or Hispanic or Latino, however, have lower rates of
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current smoking. Due to our large majority of non-Hispanic whites we were unable to
account for other racial/ethnic differences beyond two groups. Many differences in
smoking based on race can be explained by differences in socioeconomic factors (Nollen
2019). One study showed that cessation counseling by a primary care provider was less
likely to occur in non-Hispanic other race individuals, similar to females when compared
to their male counterparts (Bailey 2018). Certainly, males have a higher smoking
prevalence in the general population. But males are also more positively impacted by
cessation interventions, possibly accounting for our finding. Cessation interventions are
often thought to work the same across genders (Bottorff et al. 2014), or may only differ
based on biological factors, ignoring social gender-specific issues. This assumption is in
contrast to the evidence that quit rates differ significantly between genders. Thus, it is
important to be aware of the differences between genders in the reasons and theory
behind their smoking behaviors in order to be able to develop and implement effective
interventions. The mechanisms behind the differences based on race/ethnicity and gender
are not well-understood (Department of Health & Human Services 2014).
Social stress may be one mechanism for increased smoking between disparate
groups based on factors like fundamental causes. Social stress can be caused by social
isolation or by inclusion in society that “fails to provide the expected returns”
(Aneshensel 1992). Increased levels of chronic social stress based on race/ethnicity and
gender may occur due to barriers in achievement, resource deprivation, and social and
economic hardship (Eckenrode 1984). But there are also baseline differences in stress
between racial groups, for instance, that do not seem to be caused by typical areas of
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chronic stress (Bratter and Eschbach 2005). It would be interesting to examine in future
research the reported levels of social stress experienced by hardened smokers to
determine social stress as a possible mechanism behind smoking behaviors. There may
also be a need to capture more racial/ethnic (or gender) variation to capture socially
caused mechanisms for differences in smoking behaviors.
Hardened smokers have not been well-described in previous research. This is the
first study to illustrate socioeconomic and sociodemographic factors i this population. By
documenting differences between current and former hardened smokers based on income,
race, and gender, we can start to explore possible mechanisms for these differences, and
importantly, determine mechanisms that might help with cessation. For example, it is
possible that screening for income, race, and gender, prior to LCS decision-making
discussions could be possible in order to provide extra, or different, cessation strategies.
Indeed, one strategy does not fit everyone. It may be necessary to encourage cessation
with financial incentives, for instance, or to include counseling that involves discussions
of racial- or gender- based stressors and how to minimize those stressors. It is also
important to document differences within hardened smokers since the differences may
equate to relevant costs in other areas of sociological interest such as crime, educational
achievements, or social mobility or cohesion (Aneshensel 1992).
This study is ongoing and more data on smoking patterns are being collected. We
will be studying whether or not these findings are predictive of cessation for current
smokers at baseline. Our follow-up surveys also query patients about their decisionmaking discussion. It is possible that those with fewer socioeconomic factors are less
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likely to be influenced by provider communication within the discussion. We will also
able to evaluate this hypothesis and possible mechanisms for our findings, such as
communication quality, self-efficacy, and decisional conflict.
There are limitations to this research. We did not examine mechanisms for these
findings, but further analyses and our qualitative work can provide nuance and insight
into pathways. Since information was self-reported, participants might say what they
think the researchers want to hear, also called moderator acceptance bias. The goal of this
study was to establish a baseline of the existing resources among hardened smokers and
thus focused on cross-sectional data. However, the longitudinal design offers an
opportunity to assess responses over time and will be used to compensate for the
limitation of capturing just one snapshot in time. Smoking can be a sensitive topic, so it is
possible patients did not recall or report their smoking status accurately. We can address
consistency with our ongoing data collection.
Conclusion
Our findings suggest that patients offered LCS may be different compared to
patients in other settings where socioeconomic factors seem to play more of a role in
smoking behaviors. Smoking cessation programs could tailor their approach to patients
offered LCS who may have other individual- or system- level characteristics that
influence the association between socioeconomic and sociodemographic factors, smoking
status, and smoking cessation. Support for new interventions are crucial to address
disparities. To address some possible mediating characteristics, we plan further analyses
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to examine changes in smoking behaviors over time and associations with patientclinician communication and patient self-efficacy scores.
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Table 1. Self-reported Descriptive Statistics of All Subjects, n=404
N
Percentage* Mean
Smoking Status at Baseline
Current smoker
Former smoker
Accepted Lung Cancer Screening LDCT
Education
High school or less
Some college/vocational work
College graduate or more
Employment status
Not employed (retired, unemployed,
disabled)
Employed (full time, part time, and/or
irregular work)
Income
<$19,999
$20,000-39,999
$40,000-59,999
$60,000-79,999
>$80,000
Refused/Don’t Know
Race/ethnicity
Non-Hispanic White
All Others
Refused
Marital Status
Married
Divorced/Separated/Widowed
Never Married
Treatment location
VA Portland Health Care System
VA Minneapolis
Duke University

229
175

57
43

395

98

135
187
82

33
46
20

309
95

76
24

100
102
97
50
43
12

25
25
24
12
11
3

342
61
1

85
15
<1

191
183
30

47
45
7

204
130
70

51
32
17

n/a

Std.
Deviation
n/a

n/a
n/a

n/a
n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

n/a

Age (yr.)
n/a
n/a
65
Gender
n/a
Male
351
87
*Percents are of non-missing data and may not add up to 100% due to rounding

5.6
n/a
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Table 2. Bivariate Statistics Reporting Differences between Current and Former Smokers

Characteristic

Accepted Lung Cancer Screening LDCT
Education
High school or less
Some college/vocational work
College graduate or more
Employment status
Not employed (retired, unemployed, disabled)
Employed (full time, part time, and/or irregular
work)
Income
<$19,999
$20,000-39,999
$40,000-59,999
$60,000-79,999
>$80,000
Refused/Don’t Know
Race/ethnicity
Non-Hispanic White
All Others
Marital Status
Married
Divorced/Separated/Widowed
Never Married

Current
N= 229
N (%) *
Or
Mean (SD)

Former
N= 175
N (%) *
Or
Mean (SD)

P-value

224 (98)

171 (98)

0.42
0.11

85 (37)
104 (45)
40 (17)

50 (29)
83 (47)
42 (24)

172 (75)
57 (25)

137 (78)
38 (22)

72 (31)
57 (25)
46 (20)
29 (13)
19 (8)
6 (3)

28 (16)
45 (26)
51 (29)
21 (12)
24 (14)
6 (3)

186 (81)
43 (19)

156 (89)
19 (11)

101 (44)
107 (47)
21 (9)

90 (51)
76 (43)
9 (5)

0.46

0.007

0.03

0.17

Treatment location
VA Portland Health Care System
101 (44)
103 (59)
VA Minneapolis
73 (32)
57 (33)
Duke University
55 (24)
15 (9)
Age (yr.)
64 (5.5)
66 (5.5)
Gender
Male
189 (83)
162 (93)
*Percents are of non-missing data and may not add up to 100% due to rounding
Bold indicates statistical significance

0.48

0.35
0.003
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Abstract
Objective: Insurers have now agreed to extend coverage for lung cancer screening (LCS)
using low-dose computed tomography (LDCT), but one stipulation for reimbursement is
to deliver a shared decision-making discussion for the patient and clinician to include
communication about smoking. It is unknown if the presence of communication about
smoking positively influences smoking cessation within the LCS decision-making
discussion.
Methods: We surveyed patients eligible for LCS and who underwent a decision-making
discussion from three medical centers in the US with established LCS programs (two VA
and one non-VA). We enrolled patients before the LDCT for those who accepted the
LDCT, and within three weeks of the decision-making discussion for those who did not
accept the LDCT. Each were also surveyed after one year. We summarized the
descriptive data for demographic variables and the scores on self-report measures for all
participants. We performed a logistic regression analysis to determine the association
between patient-clinician communication and smoking status at one-year follow-up.
Results: Our sample consisted of 135 total participants who were currently smoking at
baseline: the majority (81%) were still smoking at one-year follow-up and 94% accepted
the LDCT. Almost half reported attending some college or vocation work (45%), and
76% were not employed at the time of the survey. The plurality had an income of less
than $20,000 per year (35%). Recalling having discussed smoking cessation during the
LCS decision-making discussion was not significantly associated with successfully
quitting smoking (OR 1.18; 95% CI, 0.43-3.19; P = 0.74). We found that participants at
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our non-VA site had a significantly higher odds of quitting than those at our VA sites
(OR 4.94; 95% CI, 1.29-23.34; P = 0.02).
Conclusion: Our results indicate that the LCS decision-making discussion may not be the
most influential moment to talk about smoking cessation. Indeed, future policies may not
need to mandate communication about smoking during the LCS decision-making
discussion.
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Introduction
The LCS Decision-Making Discussion
Lung cancer screening (LCS) using low-dose computed tomography (LDCT) has
been recommended by several institutions (Bach et al. 2012; Jacklitsch et al. 2012;
Moyer 2014; National Comprehensive Cancer Network 2012).The Centers for Medicare
and Medicaid Services (CMS) has agreed to extend coverage for LCS. These
recommendations, however, were not without stipulations (Jensen et al. 2015). For
instance, insurers require a shared decision-making discussion, which includes a full
dialogue about smoking behaviors prior to receipt of the LDCT. Because a decision
requiring a shared decision-making discussion is unprecedented among insurers, much is
still unknown about how communication within the discussion can positively influence
smoking cessation.
A systematic review (Joosten et al. 2008) showed that shared decision-making is
“particularly suitable for long-term decisions,” and can improve patient satisfaction and
treatment adherence (Golden et al. 2016; Legare et al. 2018). However, LCS decisionmaking discussions vary in the amount and type of information provided to a patient. For
example, clinicians cite time restraints and lack of in-depth information about LCS and
the decision-making process as reasons why they may or may not discuss smoking
cessation and other elements with patients (Melzer et al. 2019). Shared decision-making,
at least as described in the most literature (Joosten et al. 2008; Legare et al. 2018), may
not be occurring as intended. To date it is unknown if clinicians are actually discussing
smoking within the decision-making discussion as mandated. Certainly, impacts of
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shared decision-making on smoking behaviors, especially within LCS, have limited
evidence (Slatore et al. 2014; Golden et al. 2020). As a result, it is unknown what factors
may or may not be associated with positive changes in smoking behaviors (Kathuria et al.
2018; Slatore et al. 2014) within the LCS decision-making discussion.
Communication
Communication encompasses more than shared decision-making (Figure 1).
Given the importance of smoking cessation, this study focuses on whether or not patientreported presence of communication about smoking within an LCS decision-making
discussion affects cessation. Indeed, high-quality patient-clinician communication can
improve patient-centered outcomes like smoking cessation and abstinence, as well as
increased exercise and other positive health behaviors (Institute of Medicine [IOM] 2013;
Mead and Bower 2000; Simpson et al. 1991; Weiland et al. 2012). For these reasons,
effective communication between patient and clinician is often considered a part of highquality care (IOM 2013). A 2008 report published by the Agency for Healthcare
Research and Quality recommends that “every individual entering a health care setting”
should have their smoking status assessed and clinicians should advise their patients who
smoke to quit (2008 PHS Guideline Update Panel, Liaisons, and Staff 2008). Research
based on a meta-analysis shows that even brief advice given by a physician (Lancaster
and Stead 2004), or by other clinicians (Bao, Duan, and Fox 2006), can significantly
increase cessation rates. Additionally, another meta-analysis has shown that any type of
communication within a cessation intervention is more effective than self-help or no
communication (Hollis et al. 2000). Just the presence of talking to patients about smoking
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during a clinical encounter is associated with increased cessation rates anywhere from 350% depending on the nicotine dependence of the smoker (Hartmann 2000). These
findings underscore that when clinicians ask patients about their smoking at any
encounter, it has been shown to lead to reduced smoking (Bailey et al. 2018; U.S.
Preventive Services Task Force 2017). Despite these empirical studies, it is not known if
communication about smoking occurs within the LCS decision-making discussion and
how that presence of communication influences smoking cessation . Findings of this
study may point to mechanisms for improved smoking behaviors.
Methods
Setting
We surveyed patients eligible for LCS and who underwent a decision-making
discussion from three medical centers in the US with established LCS programs: VA
Portland Health Care System (VAPORHCS), Portland, OR; Minneapolis VA Medical
Center, Minneapolis, MN; and Duke University Medical Center, Durham, NC. We
recruited patients based on research referrals from clinicians who verified clinical criteria
(Miranda et al. 2017) not further confirmed by the research team. Notably, all patients in
this sample received a decision-making discussion.
Sample
We included patients regardless of whether they agreed or declined to undergo
the LDCT. The study was IRB-approved at each participating site (VAPORHCS #3482;
Minneapolis VA #4645-B; Duke #Pro00073394). The Portland State University Office of
Research Integrity and IRB waived oversight of this study (see Appendix F). We enrolled
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patients after their decision-making discussion with their clinician, and data were
collected at baseline and one year. We collected baseline data at time points depending
on if the patient accepted or declined the LDCT: before the LDCT for those who
accepted the scan, and within three weeks of the decision-making discussion for those
who did not accept the LDCT. We collected one-year follow-up data for all patients,
again timing depended on if they accepted or declined the LDCT. That is, one year after
the scan for those who accepted the LDCT, and one year after the decision-making
discussion for those who declined the LDCT. For this analysis we included current
smokers at baseline, identified by their response to the question, “How would you
describe your cigarette smoking?” There were no patients who started smoking after
baseline and we did not include former smokers at baseline since we were most interested
in smoking cessation at one-year follow-up.
Data
We enrolled 414 patients in the study who completed quantitative surveys, of
whom 135 who were currently smoking at baseline and had a response for smoking status
at one-year follow-up, and thus included in this analysis. At the initial and follow-up
study visits, we collected data on the independent and dependent variables. At the initial
visit only we collected sociodemographic data, pack years, and e-cigarette use .
Primary Outcome
We defined smoking status at one-year follow-up based on the question, “Have
your smoking habits changed since the last survey?” We classified patients as having
successfully quit if they responded that they had quit smoking at least 7 days ago, based
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on a commonly used measure of successful tobacco cessation by the 7-day point
prevalence abstinence (Velicer and Prochaska 2004).
Primary Exposure
We measured communication using one question from a survey instrument based
on work by Borrelli (Borrelli et al. 2001; Borrelli, Lee, and Novak 2008). The question
asks, “Did the person who talked with you most about screening discuss quitting smoking
with you?” The response options include: No, Yes, and Could Not Recall. Two previous
studies by Borrelli used this instrument to determine that attitudes and beliefs about
smoking are significantly associated with counseling behaviors for nurses providing
information about smoking cessation (Borrelli et al. 2001), and to compare
communication quality of nurses providing cessation (Borrelli, Lee, and Novak 2008).
The entire instrument is 16 questions, however there is not a summary index available,
only individual questions are used. We also found that 72 (53%) of participants either
Could Not Recall or reported No, they did not have a decision-making discussion,
therefore they skipped the rest of the instrument and greatly reduced our sample size.
Additionally, as discussed above, even brief communication regarding smoking cessation
can have an impact on patient health behaviors. We combined the No and Could Not
Recall responses for our analysis.
Covariates
We adjusted for study site location: VAPORHCS, VA Minneapolis, and Duke
University. We also adjusted for nicotine dependence. We measured nicotine dependence
using one question from the Fagerström Test for Cigarette/Nicotine Dependence: “How
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soon after you wake up do you smoke your first cigarette?” This question was found to be
most predictive of nicotine dependence (Heatherton et al. 1991).
Analysis
We first summarized the descriptive data for sociodemographic variables and the
scores on self-report measures for all participants. Next, we conducted t-tests or ChiSquared tests to see potential compositional differences between people who were able to
quit and those who were not able to quit smoking. We then estimated a logistic regression
analysis to determine the association of presence of patient-clinician communication with
smoking status at one-year follow-up. The primary models were constructed
parsimoniously, excluding variables that did not appear to be confounders if the marginal
effect was not more than 10%. We also performed a sensitivity analysis separating the
Could Not Recall and No discussion responses into two variables. We used STATA v.16
for analysis, employing p<0.05 criterion for statistical significance.
Results
Table 1 displays the characteristics of the 135 participants included in this
analysis. All included participants completed the baseline and one-year follow-up survey,
including responding to the independent and dependent variables questions. The majority
(81%) were still smoking at one-year follow-up and 94% accepted the LDCT. Almost
half reported attending some college or vocational work (45%), and 76% were not
employed at the time of the survey. Additionally, the plurality reported an income of less
than $20,000 per year (35%). Eighty-four percent of participants were non-Hispanic
white and 85% reported male gender. Half of participants were
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divorced/separated/widowed (50%) and 7% used e-cigarettes at baseline. Given the
eligibility criteria to be offered LCS, it follows that our average age was 64, with 49
average pack years of smoking. Almost half of participants reported discussing smoking
cessation during their LCS decision-making discussion (47%), while 39% reported not
discussing smoking cessation, and 15% could not recall discussing smoking cessation.
The only significant comparison was for study site location (P = 0.04).
We provide the odds ratios for the association of presence of patient-clinician
communication about smoking cessation and cessation outcomes in Table 2. Recalling
having discussed smoking cessation during the LCS decision-making discussion was not
significantly associated with lower odds of successfully quitting smoking (OR 1.18; 95%
CI, 0.43-3.19; P = 0.74). We also found that a significantly higher odds of quitting among
the participants at Duke University than those at VAPORHCS (OR 4.94; 95% CI, 1.2923.34; P = 0.02). Our sensitivity analysis separating the Could Not Recall from the No
discussion options did not lead to a reliable result since after doing a crosstabulation of
the original groups, we found only 7 patients in the Could Not Recall /quit smoking
group.
Discussion
We found that our respondents who did report discussing smoking cessation
during their LCS decision-making discussion had lower odds of successfully quit
smoking at one year compared to those who could not recall or said no, although this was
not statistically significant. Despite past literature finding otherwise, communication was
not found to be associated with smoking cessation in people who currently smoke. We
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offer three plausible explanations for the unexpected finding. First, given that discussions
of smoking cessation are required and encouraged by several organizations, it is likely
that most (if not all) patients, even those who could not recall, did have a decisionmaking discussion to include talk of smoking cessation. In addition, most patients
qualitatively report having smoking behaviors discussed by their clinicians within routine
and LCS-related encounters (Golden et al. 2020). Thus, it is possible that the participants
who could not recall or did not report having a discussion of smoking had differing
cognitive abilities or baseline anxiety regarding lung cancer or LCS. Anxiety and distress,
age, and perceived importance of medical information can all create recollection issues,
but even without these factors, “memory for medical information is often poor and
inaccurate” (Kessels 2003). Therefore, all patients who participated in our study may
have subconsciously picked up on the importance of smoking cessation. Or more likely,
patients may have focused more on the fact they were at high risk of lung cancer and
realized that smoking cessation was the best way to reduce their chance of being
diagnosed with lung cancer. Indeed, most patients in our study already realize that
smoking causes lung cancer and want to make the decision to quit themselves (Golden et
al. 2020), perhaps above and beyond communication during the LCS decision-making
discussion. An interesting addition to the model would be self-efficacy scores. We did
collect self-efficacy scores, however there were so many missing responses, it would
have greatly diminished our sample size.
Second, study site location, which was significant in our analysis, can be seen as a
proxy for socioeconomic status (SES). Our sites were chosen purposively to collect data
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from diverse socioeconomic and sociodemographic populations, as different sites may
reflect different levels of SES of patients in general. Those with a lower SES are more
often current smokers when compared to those with a higher SES (Marmot and
Wilkinson 2006), and those with a higher SES tend to have more resources for trying to
quit smoking. Since Duke University, for instance, may have more private-pay patients,
their patients may be more likely to have more resources that are not captured by our SES
variables (i.e. education, employment, and income). They may have access to other
resources that may be helpful to quit smoking compared to patients at other sites, like
possibly greater family support or other factors not captured here that may influence
smoking status more than presence of communication. Additionally, those from lower a
SES may have lower health literacy and may not be able to interpret the discussion about
smoking behaviors as easily as those from a higher SES. Low health literacy, indeed,
effects an estimated 36% (80 million adults) of the US population (Kutner, Greenberg,
and Baer 2006) and it disproportionately impacts people from socioeconomically
disadvantaged groups (Mantwill, Monestel-Umana, and Schulz 2015; Hayward et al.
2000). Not only could SES differences in site lead to different levels of self-efficacy, but
so could their proactive choice to join a cessation clinic. Indeed, SES can impact
psychological and social factors like self-efficacy and willingness to quit and senses of
control over their health behaviors.
Finally, study site location is also a proxy for willingness to quit smoking.
Certainly, Duke University participants were recruited from a dedicated smoking
cessation clinic and possibly felt more self-efficacy to be able to quit smoking. They
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proactively enrolled into smoking cessation counseling clinic where LCS was discussed
within their smoking cessation clinician encounter. Participants at Duke, therefore, were
likely more motivated to quit smoking and felt more selfefficacy compared to the other
sites and these characteristics may explain the significance of the study site location
variable in our analysis. Self-efficacy and sense of control can be influenced by many
factors, so it is possible that future interventions may need to identify how underlying
factors like SES or willingness to quit, impact them.
Moving forward, our finding should be interpreted with caution. Because active
participation in health care, including effective communication between patients and
clinicians, has many benefits, we should note that some patients may lack the necessary
skills to ask relevant questions and to advocate for themselves and their health. It is
possible our measurement of communication did not capture the importance of a dialogue
between patients and clinicians. The measurement of communication did not ask about
quality, patient-reported satisfaction, or rank the effect of the impact of the
communication on their smoking behaviors. Clinicians also may lack necessary
communication skills (D'Agostino et al. 2017). So even though clinicians may have
discussed smoking with our patients, the discussions may not have incorporated all
domains of patient-centered communication. All of the patient-centered communication
domains are amenable to training though, (D'Agostino et al. 2017) and improvements in
all domains lead to better health outcomes, like smoking cessation. For example,
Lindson-Hawley and colleagues found that motivational interviewing is one form of
communication that can lead to improved smoking cessation (2015).
98

Communication strategies are critical factors in improving patient-centered
outcomes for those with and at-risk of cancer (Epstein and Street 2007; IOM 2013).
Indeed, “medical care is fundamentally a communicative enterprise in which clinicians
[and] patients discuss a patient’s health, decide on the best therapeutic action, and make
plans [on] those decisions” (Street et al. 2009). While the LCS decision-making
discussion itself may not influence smoking cessation, subsequent abnormal findings or
diagnoses may prove to be a more beneficial time to talk about the importance of
smoking cessation (Slatore et al. 2014). Communication in all encounters, however,
remains imperative, especially since repeated encounter to include talk of smoking have
been shown to have more impact on smoking behaviors (Bailey et al. 2018). More
research should be done on how communication impacts health behaviors within the
unique LCS decision-making discussion.
Limitations
The study does have limitations. First, while the inclusion of multiple sites
increases the generalizability of the study, there remains a limitation due to the majority
of the cohort being Veterans. Veterans are more likely to be male and Caucasian.
However, our previous qualitative work among Veterans and non-Veterans has
uncovered similar themes about deficits in patient-centered care (Golden et al. 2016).
Second, this study suffers from reporting bias, in that those who participate may be more
likely to report higher incidence or quality of communication. This may have impacted
our findings to show a bias towards presence of communication. Future research in this
area could benefit from audio or visual confirmation of communication about smoking
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occurring during the LCS decision-making discussion. The third limitation is selection
bias. We found that patients unwilling to undergo the LDCT were also unwilling to
participate in our research study, limiting our ability to document those who decline the
LDCT. Participants agreeing to undergo the LDCT will likely have significant
differences compared to participants who decline to undergo the LDCT and should be
investigated further. Fourth, this study suffers from recall bias; it is possible that
participants may not recall, or want to recall, certain items. Participants might say what
they think the researchers want to hear, also called moderator acceptance bias. Timing
may not capture overall feelings since each survey captures just one snapshot in time.
Finally, I did not investigate specific mechanisms.
Conclusion
Our results indicate that the LCS decision-making discussion may not be the most
influential moment to talk about smoking cessation. Although we did not find a
significant association, even a null finding can be informative for future work. Indeed,
future policies may not need to mandate communication about smoking during the LCS
decision-making discussion. Also, future research can be informed about what should be
included or not in subsequent analyses. While we did not investigate specific
mechanisms, it remains imperative to first determine the association of perceived quality
communication with a health outcome, which can serve as a foundation for future studies
about proximal and intermediate outcomes.
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Figure 1. Patient-Centered Communication Model
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Table 1. Characteristics of Patients who are Currently Smoking Offered Lung Cancer Screening
N=135
Quit
Did not quit
smoking
smoking
N (%)*
p-value
N (%)* Or
N (%)* Or
p-value
Or Mean
from
Mean (SD)
Mean (SD)
from t-test
Characteristic
(SD)
chi-2
Accepted lung cancer
screening LDCT

127 (94)

25 (100)

102 (93)

0.38

n/a

50 (37)

12 (48)

38 (35)

0.42

n/a

61 (45)

10 (40)

51 (46)

College graduate or more

24 (18)

3 (12)

21 (19)

Employment status
Not employed (retired,
unemployed, disabled)
Employed (full time, part
time, and/or irregular work)

103 (76)

20 (80)

83 (75)

0.75

n/a

30 (22)

5 (20)

25 (23)

2 (1)

0 (0)

2 (2)

<$19,999

47 (35)

7 (28)

40 (36)

0.31

n/a

$20,000-39,999

29 (21)

3 (12)

26 (24)

$40,000-59,999

34 (25)

10 (40)

24 (22)

$60,000-79,999

14 (10)

2 (8)

12 (11)

>$80,000

9 (7)

2 (8)

7 (6)

Refused/Don’t Know

2 (1)

1 (4)

1 (1)

Non-Hispanic White

114 (84)

24 (96)

90 (82)

0.08

n/a

All Others

21 (16)

1 (4)

20 (18)

56 (41)

15 (60)

41 (37)

0.11

n/a

67 (50)

9 (36)

58 (53)

12 (9)

1 (4)

11 (10)

57 (42)

5 (20)

52 (47)

0.04

n/a

VA Minneapolis

55 (41)

13 (52)

42 (38)

Duke University

23 (17)

7 (28)

16 (15)

Age, in years (SD)

64 (5.7)

66 (5.3)

64 (5.8)

n/a

0.17

Male gender

115 (85)

20 (80)

95 (86)

0.42

n/a

9 (7)

3 (12)

6 (5)

0.25

n/a

8 (6)

1 (4)

7 (6)

Education
High school or less
Some college/vocational
work

Refused
Income

Race/ethnicity

Marital Status
Married
Divorced/Separated/Widowed
Never Married
Treatment location
VA Portland Health Care
System

Currently use e-cigarettes
Missing
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Average pack years (SD)

49 (23)

57 (25)

47 (23)

4

2

2

Yes

63 (47)

13 (52)

50 (45)

No

52 (39)

6 (24)

46 (42)

20 (15)

6 (24)

14 (13)

Missing

n/a

0.09

0.55

n/a

n/a

n/a

Cessation Discussed

Could not Recall
Smoking at one-year followup

110 (81)

110 (100)

*Percents may not add up to 100% due to rounding
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Table 2. Odds Ratios for the Association of Patient-Clinician Communication about
Smoking Cessation and Cessation Outcomes
Characteristic
Cessation discussed
Yes
No/Could not Recall
Time to First Cigarette
Over 30 minutes
Under 30 minutes
Site
VA Portland
VA Minneapolis
Duke University

OR (95% Confidence
Interval)

P Value

Reference
1.18 (0.43-3.19)

0.74

Reference
0.55 (0.22-1.38)

0.20

Reference
3.08 (1.00-9.46)
4.94 (1.21-20.12)

0.05
0.03
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Abstract
The importance of communication using a specific strategy recommended by the U.S.
Preventive Services Task Force, the 5A’s (Ask, Advise, Assess, Assist, Arrange), in
addition to the psychosocial resource of self-efficacy, are widely discussed in smoking
cessation literature. However, the use of the 5A’s and the importance of self-efficacy is
less well-understood in the context of lung cancer screening (LCS). We use the LCS
decision-making discussion to examine these concepts and their relation to smoking
cessation. We used in-depth interviews focused on how patients and clinicians
communicate about smoking and performed a qualitative evaluation of the experiences of
51 former or current smokers and 24 clinicians.
Patients and clinicians agreed that communicating about smoking cessation is an
important aspect of care, especially through use of the 5A’s. Clinicians viewed the LCS
decision-making discussion as an opportunity to offer support and enhance the likelihood
of cessation and commonly indicated efforts to minimize patient distress. Further, all
reported regular use of the first three A’s (Ask, Advise, Assist) and considered the LCS
decision-making discussion a unique opportunity to do so. Comparatively, patients
appreciated these discussions in the LCS context but felt the decision to pursue cessation
was unrelated to the decision-making discussion. Both groups agreed that the decisionmaking discussion was less important than a patient’s sense of readiness and selfefficacy. Nonetheless, our findings suggest the use of the 5A’s is concordant with the
patient’s perceptions of quality patient-clinician communication, which has the potential
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to improve trust and self-efficacy. While the LCS decision-making discussion is
perceived as less impactful than other motivations with respect to cessation, it represents
a key avenue through which to aid a major behavior change like smoking cessation. The
potential of the decision-making discussion to improve smoking outcomes should receive
continued investigation.

114

Introduction
Lung Cancer Screening
Smoking is the number one preventable cause of death and disease in the United
States (US) (Centers for Disease Control and Prevention 2018) and is linked to 80-90%
of all lung cancers. Lung cancer has the highest cancer mortality rate in America (Siegel,
Miller, and Jemal 2016). Lung cancer screening (LCS) using annual low-dose computed
tomography (LDCT) reduces the relative risk of lung cancer mortality by 20%. LCSis
now recommended for high-risk smokers by several organizations such as the US
Preventive Services Task Force (USPSTF) (Moyer 2014), the American Cancer Society
(Wender et al. 2013), and others (National Comprehensive Cancer Network 2012; Bach
et al. 2012; Jaklitsch et al. 2012; Samet et al. 2012).
The Centers for Medicare and Medicaid Services (CMS) agreed to include LCS as
a reimbursable service in 2015 (Jensen et al. 2015), though this came with several
stipulations and suggestions (Jensen et al. 2015; Mazzone 2018; Wiener 2015). CMS
mandated a shared decision-making discussion using a decision aid to help patients
decide whether to receive the LDCT or not. A qualified practitioner must also
communicate about smoking abstinence and offer cessation services to active smoker
within the decision-making discussion. To date, no guidelines have been developed as to
what qualifies as shared decision-making for LCS or how to provide this discussion
appropriately to patients, especially regarding smoking cessation counseling. Formally,
our research question herein is: How do patients and clinicians communicate about
smoking within an LCS decision-making discussion? We aim to provide clarity about the
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use of a communication technique to provide smoking cessation counseling, the 5A’s, in
addition to the role of self-efficacy, and motivations for cessation, within the LCS
decision-making discussion.
Routine Discussion of Smoking Cessation using the 5A’s
Patient-clinician communication is a key component of high quality health care
that can improve outcomes such as smoking cessation (IOM (Institute of Medicine) 2013;
Mead and Bower 2000; Simpson et al. 1991; Weiland et al. 2012). The USPSTF
specifically recommends use of the 5A’s (Ask, Advise, Assess, Assist, and Arrange)
during every clinical visit with a patient as part of quality communication for smoking
cessation that has been shown to improve outcomes (USPSTF; Fiore 2008). “Ask” refers
to identifying a patient’s smoking status; “Advise” refers to encouraging cessation in a
“clear, strong, and personalized manner”; “Assess” refers to determining the patient’s
willingness to quit; “Assist” refers to offering tailored smoking cessation strategies, such
as referrals to counseling or pharmacotherapy, or other resources; and “Arrange” refers to
scheduling follow-up to assess treatment outcomes and provide ongoing care (Agency for
Health Research and Quality 2012). The US Department of Veterans Affairs (VA) and
other medical systems have adopted use of the 5A’s via guidelines put forth by the US
Public Health Service (VA/DoD EBP 2013). It is recommended that clinicians use the
5A’s at every clinical encounter. A clinical encounter in which LCS is discussed is a
natural opportunity to perform the 5A’s. Few studies have evaluated use and
effectiveness of the 5A’s in routine care settings or across both federal and community
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sites. It is unknown if or how this strategy is used within the context of LCS decisionmaking discussions, despite the mandate for discussions of smoking cessation.
Self-efficacy
In addition to communication using the 5A’s, one’s personal feeling of selfefficacy has the potential to improve rates of cessation. Self-efficacyis conceptualized as
the internal sense of personal control someone has to produce desired effects by their
actions. Further, self-efficacy has been shown to contribute to health and well-being
(Bandura 1997; Link and Phelan 2000), and sociologists have established that this
concept has a direct link to smoking cessation (Brod and Hall 1984; DiClemente 1981;
Nicki, Remington, and MacDonald 1984; Prochaska and DiClemente 1984; Strecher et
al. 1985). For example, Gorini and colleagues found that workers with lower reported
levels of self-efficacy in smoking cessation were less likely to report 6 months of
continued smoking abstinence (Gorini et al. 2018). A meta-analysis showed that selfefficacy has a well-correlated relationship with smoking cessation as well as future
abstinence; in other words, rates of cessation and continued abstinence are improved
among those reporting higher levels of self-efficacy (Gwaltney et al. 2009).
Similarly, high quality patient-clinician communication, as in use of the 5A’s, has
been shown to lead to higher patient self-efficacy. When people receive positive
communication they may prioritize health behaviors (Dornbusch, Herman, and Morley
1996) to try and make positive behavioral changes (like quitting smoking), largely
through impacts on self-esteem and self-efficacy. Thoits (2011) and others (Cohen and
McKay 1984; Weiss 1974) have noted that positive feedback can aid in coping behaviors
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and subsequently increase self-efficacy and motivation for health behavioral change. It
may be that discussions of LCS provide positive feedback and encouragement about
smoking cessation framed as being able to change the behavior “before it’s too late.”
Importantly, patient-clinician LCS decision-making discussions can be shaped by the
patient and the clinician (Lawson 2009). Patients may interpret positive communication
as encouragement, which boosts feelings of self-efficacy, possibly leading to a greater
chance at successful smoking cessation. But the clinician perspective is also essential.
Clinicians can gauge a patient’s personal feelings of self-efficacy to use as a motivator
for cessation, or to add in positive behavioral change. However, previous qualitative
studies showed that patients’ misunderstanding about LCS and smoking cessation are
associated with continued smoking behaviors (Zeliadt 2015; Kathuria 2018); or that
discussions of LCS may cause patients to have lower motivations to quit smoking
(Zeliadt 2015). Accordingly, it is necessary to investigate both the perceived importance
of LCS decision-making discussions to improve rates of smoking cessation.
Individual Characteristics for the LCS-Eligible Population
According to CMS reimbursement schedules, patients who are eligible for LCS
are those with a significant smoking history (e.g. >30 pack-years) and are middle-aged or
elderly adults. Active smokers in this cohort are often classified as “hardened” smokers1
who are “less likely to be influenced by cessation measures” (Ney et al. 1989). Hardened
smokers often have no intention to quit or find it very difficult to quit (Docherty and

The authors acknowledge the pejorative nature of the term “hardened” smokers. However previous and
current literature utilizes this term and we found no more appropriate term to use.
1
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McNeill 2012). Hardened smokers are also more likely to come from disadvantaged
backgrounds (Lund, Lund, and Kvaavik 2011), which is an independent risk factor for
inability to abstain from smoking (Jarvis 2006 in Marmot; Tsai 2011; Smith 2015;
USDHHS 1990). Despite the difficulties with smoking cessation, hardened smokers are
an important population to target because it is never too late to quit smoking (Maryland
Resource Center for Quitting Use & Initiation of Tobacco) and they need the most
assistance. Despite knowing the importance of cessation, hardened smokers are often
unable or unwilling to quit (Warner 2003). We know less about effective cessation
strategies because they do not frequently enroll in trials (Zbikowski 2012) or because
they are excluded from trials due to comorbidities (Docherty 2012). These omissions
make knowledge about how to help them quit important to understand. To this end, we
wanted to examine how hardened smokers and clinicians communicate about smoking in
the context of an LCS decision-making discussion.
Methods
We evaluated qualitative data on the experiences of former or current hardened
smokers who underwent LCS decision-making discussions and clinicians (primary care
clinicians, pulmonologists, or LCS nurse, physician assistant, or advanced practice nurse
coordinators) from three medical centers in the US with established LCS programs: VA
Portland Health Care System (VAPORHCS), Portland, OR; Minneapolis VA Medical
Center, Minneapolis, MN; and Duke University Medical Center, Durham, NC. We
strategically chose these sites to include participants with demographic diversity across
racial, ethnic, and urban/rural domains. We conducted interviews between April 2016 and
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November 2017. All participants completed the informed consent process either by phone
or in-person before the first interview using IRB-approved documents. The study was
IRB-approved at each participating site (VAPORHCS #3482; Minneapolis VA #4645-B;
Duke #Pro00073394).
Patient Sample
We enrolled 51 patients who were eligible for LCS based on research referrals
from clinicians, who verified clinical criteria not further confirmed by the research team.
We used purposive recruitment for qualitative interviews to oversample minorities. We
limited enrollment to patients who were eligible for LCS based on their local institution’s
criteria, which were similar to USPSTF eligibility criteria (Miranda 2017). We limited
enrollees to English speakers, either as a primary or secondary language. We included
patients regardless of whether they agreed or declined to undergo the LDCT scan (herein,
‘LCS’ refers to the process of screening while ‘LDCT’ refers to the scan itself).
Clinician Sample
We recruited 24 clinicians based on identification by the local site PIs as being
involved in the LCS decision-making process. We initially recruited clinicians via an
emailed invitation letter. We conducted one-time, semi-structured, in-depth qualitative
interviews.
Data Collection
We conducted in-person and telephone interviews using a semi-structured
interview guide that included many questions about communication in general, as well as
questions focused on communication about smoking (Appendix E). The interview guides
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allowed for other themes, additional information, and follow-up questions to emerge. The
qualitative analyst (SEG) conducted all interviews in a private space. The principle
investigator was a pulmonologist involved in offering and directing LCS at one of the
sites as well as in assisting with smoking cessation, so we had two impartial investigators
(SEG and SSO) lead the interview and analytic process to mitigate bias. We digitally
recorded and transcribed the interviews, removing identifiers during transcription.
Participants are identified by a letter “P” followed by randomly assigned letters or “C”
followed by randomly assigned numbers not related to name or treating hospital system
for patients and clinicians respectively. Individual participants are referred to as “she/her”
to protect anonymity. Per our original research question aimed at focusing on
communication practices, we achieved saturation of two main themes (Patton 2002; Pope
et al. 2006): Role of the 5A’s in Quality of Communication; Role of Self-efficacy and
Motivators in Smoking Cessation. Participants self-reported demographic (patients and
clinicians) and smoking characteristics (patients only) prior to the first interview.
Analysis
We used ATLAS.ti 7.1.7 (ATLAS.ti GmbH, Berlin, Germany) to organize and
support conventional content analysis of the qualitative data. We identified codes
previously as key concepts based on the interview guide and developed other codes as we
identified themes in the data. Throughout the analytic process, we evaluated any
overlapping coding or un-coded text to verify appropriateness. We developed initial and
integrative memos throughout to capture thoughts or analytic ideas, which aided in the
final interpretation of the data through identifying patterns and variations in the
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transcripts. We also utilized an audit trail for tracking of modifications and decisions
related to the codebook and qualitative analysis.
Results
Participant Characteristics
We interviewed 51 patients and 24 clinicians. At baseline, 33 patients were
currently smoking, 18 were former smokers (one had quit within the last month). Fortythree patients accepted the LDCT, 6 declined, and 2 were undecided at the baseline
interview. Over half of patients were from VA sites, however, we did not find
substantially different responses from subjects across the three study site locations apart
from patients at Duke enrolled in a specialized smoking cessation clinic, as discussed
above. Clinician distribution was equal between study site locations and we did not find
substantially different responses between sites for clinicians. We did not note any
discernible patterns based on demographics. The average age of our patient sample was
63 years, with mostly white (83%), and male-identified (76%) participants (Table 1).
Clinician participants were an average age of 42 years, 75% white, and 33% identified as
male. Most were primary care providers (PCPs) (42%) (Table 2).
Below we organize our results under the following themes 1) Role of the 5A’s in
Quality of Communication; 2) Role of Self-efficacy in Smoking Cessation and
Motivation in Cessation. We first introduce the theme, then report findings for patients
and, subsequently, clinicians.
Theme 1: Role of the 5A’s in Quality of Communication
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We first report how patients and clinicians communicate about smoking,
specifically using the recommended 5A framework.
Patients
Patients reported that at all clinical visits, even those prior to the LCS decisionmaking discussion, they were Asked about smoking “gently” and respectfully Advised to
quit, but only sometimes Assessed for their readiness (the first three of the 5A’s). Patients
reported they understand it is the clinician’s job to discuss smoking abstinence at each
visit, no matter the indication for the visit, saying: It’s just part of the deal. (P-XX).
Patients indicated this was an expected conversation as part of a quality clinical
encounter. The majority of patients reported that the clinician Asking, Advising, and
Assessing did not influence their desire to quit or abstain from smoking, either positively
or negatively.
Despite reporting that the LCS decision-making discussion did not necessarily
influence their desire to quit smoking compared to discussions at other clinical visits,
most did agree that it was a convenient and understandable time for the clinician to
address smoking since the discussion included mention of lung cancer. All patients
reported the LDCT was not an appropriate substitute for cessation, even without clear
Advising, Assessing, or Assisting. Importantly, all patients reported that they viewed LCS
and smoking as two separate decisions (i.e., to undergo screening vs. to quit smoking).
Patients emphasized that patients needed to feel ready to quit smoking before pursuing
cessation.
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…these CT scans are just going to give a baseline… If you want to keep smoking, keep
smoking. (P-B)

I am always concerned about [my smoking] so [the LCS discussion] has not affected [my
smoking] anymore. (P-HH)
Me deciding that I needed to quit smoking had nothing to do with [the discussion or
LDCT]. (P-J)
Clinicians
Clinicians varied in their use of the 5A’s during these clinical encounters. For
example, some capitalized on the LCS decision-making discussion not only as an
additional means through which to broach the conversation but also to mitigate
potentially negative feelings associated with being Asked about smoking: I know you’re
not ready to talk about [cessation] now, but I’m just warning you I’m gonna bring it up
every single time you come in. So you know, just don’t get upset with me, it’s part of
being a doctor and I need to bring this up and point it out (C-15). In this way, the 5A’s
may offer a usable framework through which uncomfortable topics may be approached
with patients.
Others were more focused on the LCS decision-making discussion as an
opportunity to Assess readiness to quit:
[LCS] provides an opportunity to discuss the cessation. And figure out where people are
on their journey toward smoking cessation. (C-3)
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I strongly think that [LCS] should be used as a jumping off board for smoking
interventions. Not, again, necessarily because it’s a magical time to talk to people about
smoking, but just because you’ve corralled a bunch of smokers. (C-22)
Eighteen clinicians described using at least parts of the 5A framework all the
time. About half of clinicians interviewed reported explicitly Assessing patients for their
readiness to quit. The other half did not mention whether they Assessed or not. All
clinicians related that including the 5A’s in discussions with current smokers was
important and most felt the LCS decision-making discussion could be used as an
opportunity to discuss smoking. Barriers to this discussion, however, were time for the
encounter and issues related to perceived patient self-efficacy and readiness to quit. If
clinicians did not feel a patient was ready to quit, they did not want to “push” them or
make them feel ashamed for the inability to quit. No patients were provided information
or Advised about their actual risk. For patients who reported a desire to quit, clinicians
offered to Assist and Arrange resources, and ensured those patients not ready to quit were
aware that there were future opportunities for cessation resources. Clinicians reported
more variable use of Assisting and Arranging since these components related heavily to
the patient’s sense of self-efficacy.
Almost all clinicians agreed with the belief that the process of discussing or
undergoing the LDCT would not positively or negatively influence patients’ motivation
for abstinence. For example: I wish I could say that paired with offering CT scans, that
motivates people [to quit smoking], but I can’t say that’s a motivating factor. (C-16)
Clinicians did not report reframing the LDCT as a positive motivator for change. They
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did discuss potential LDCT findings as motivators for quitting, with most agreeing that a
pulmonary nodule finding would likely positively influence abstinence, however, there
were several who disagreed: [Patients] don’t perceive [a nodule finding] as a very
sentinel event in their lives and a wake-up call to quit smoking… because we kind of
minimize the impact. (C-12) There was often discussion of the balance between alarming
a patient with results to motivate them to quit or abstain from smoking and providing
accurate information about the risk of lung cancer based on the results.Some clinicians
said motivation to quit seemed to depend on if the results were presented as suspicious or
likely benign. Some acknowledged they were surprised the discussion of lung cancer risk
during prior visits with other patients did not affect smoking change in patients as much
as they would have thought: Risk doesn’t mean a lot… it’s a concept, it’s not an actual
disease that hits home for a lot of people. (C-17
Theme 2: Role of Self-efficacy and Motivators for Smoking Cessation
We next report on the role of self-efficacy in smoking cessation and on how
patients and clinicians describe which individual circumstances actually influence their
smoking behaviors.
Patients
No patients indicated their clinician connected LCS and smoking in a way that
influenced their desire to quit. The majority of patients felt it was likely helpful for some
patients to have smoking mentioned (at least Asked about) at each visit—just not for
them. If patients were not ready to quit, they felt confident they could obtain resources
when necessary – that is, they did not desire additional help with Assist at that time.
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Patient responses commonly indicated that readiness and desire to quit were of
paramount importance with respect to smoking cessation:
[LCS] don’t give me no green light to continue to smoke. Some people would think of it
as a green light to continue to smoke, but I’m wanting to quit because I’d like to live a
little bit longer. (P-II)
So [bariatric surgery] was the initial motivator, but quite frankly the motivation was the
reason for the surgery. … I need a better quality of life. And I can only get that through
better health. I’m a late learner. (P-CC)
Similar to clinicians, most patients indicated that lung cancer risk was not a
primary motivator for smoking cessation and that hearing they were eligible for LCS,
because of their smoking status and age, did not cause distress. Only two of the 32
current smokers indicated that talking about their lung cancer risk positively influenced
the desire to quit smoking since everyone had been aware for years that they are at a
higher risk of lung cancer due to smoking:
So, it’s like, well, somebody could tell me, “Smoking is not good for you. Blah. Blah.
Blah.” Well you already know that, so it’s like, “OK.” It goes in one ear and out the
other because I already know that smoking ain’t good for me. (P-PP)
It’s not gonna sway me. They’re told to [bring up smoking]. I mean, yeah, everybody
knows smoking is bad for you. (P-L)
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Notably, when asked, most patients largely overestimated their actual risk of lung cancer
but indicated that even this high risk did not cause much distress or prompt behavior
change.
Patients reported other motivations for quitting that largely did not seem to be
discussed in clinician encounters. Examples of motivations were family encouragement:
…[my] 11-year old grandson. He rides me pretty hard. (P-D) They also mentioned the
financial cost of smoking: I think about the thousands of dollars I spent on cigarettes and
I’ve been buying my girlfriend cigarettes now too for 5 years. So, yeah, it’s all pretty sick.
(P-Y) And many mentioned the impact on their overall health and quality of life:
Just the physical of it. Getting away from being in the middle of something and stopping
this to go have a cigarette. Get rid of all that. (P-JJ)
As you get older, you’ve got to put things in perspective! Like you know, 10 more good
years of having a good mind, not having a stroke, being able to walk, being able to go on
vacations. 10 years and I might not be able to do that if I don’t stop smoking! (P-P)
Patient-identified barriers mainly included: a difficult habit/addiction to break,
smoking relieves anxiety or stress, lack of desire to commit to cessation, and the act of
smoking is enjoyable. Despite these barriers, patients appreciated that their clinicians
cared enough to discuss smoking since they knew it put them at a higher risk of
developing lung cancer.
Clinicians
Clinicians did not report communicating about the LDCT as a positive motivator
for change, but most said the encounter was a good opportunity for discussion since you
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have the patient in the office. Six of the 24 clinicians reported the LCS decision-making
discussion was a unique time to talk about smoking because it elicited a different reaction
from the patient regarding increasing their desire to quit smoking compared to other
patient visits: I think it is a unique time. I think it does make them hyper-aware that
maybe [smoking cessation] is something they should start thinking about. (C-5)
Some acknowledged they were surprised the discussion of lung cancer risk during
prior visits with other patients did not affect smoking change in patients as much as they
would have thought. To that end, they did not use lung cancer risk as a motivator or
discussion point. Most clinicians did not link the risk of lung cancer to smoking cessation
for fear of making patients feel ashamed or pressured, or because they realized patients
already knew they were at some risk of lung cancer. These clinicians also reported they
often did not feel comfortable Advising specific risk values for the patient’s likelihood of
developing lung cancer: I just usually say increased risk… I don’t use numbers with my
patients. (C-25)
Clinicians discussed potential barriers to quitting with the most common being:
stress, habit, and it’s just “too hard to quit”: Most of the time it’s a habit that they’ve had
for years… we can give them medication to help with the withdrawal and the urges, and I
try to work with them with behavioral therapy and replacing those behaviors, but [the
habit] is the biggest barrier. (C-8) Several described the difficulty in quitting and how
many patients give up after trying to quit multiple times, which may make patients less
likely to be motivated by an LCS decision-making discussion:
I think a lot of them have sort of given up. (C-20)
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[Smoking] rapidly becomes not a choice. Obviously… the powerful addiction of
components are worse than cocaine. (C-24)
Discussion
Similar to previous research (Slatore 2014, Zeliadt 2015, Kathuria 2018), we
found that LCS decision-making discussions are unlikely to influence smoking behavior.
Patients and clinicians reported that clinicians mostly adhered to the 5A framework for
cessation counseling, and that self-efficacy was important through evidence of always
Assessing before Assisting. The groups diverged on their evaluation of the relative
importance of using the 5A’s at every encounter with a patient, with clinicians feeling it
to be more imperative as a form of quality communication. Importantly, while we
observed some gap in views on the importance of the clinical encounter in the cessation
process, we learned that patients felt there are more meaningful factors related to
smoking cessation. Patients mentioned personal reasons like finances or family as reasons
to quit smoking rather than the risks of lung cancer or other health problems. These
factors seem to not be currently leveraged by current clinician communication practices
to motivate positive behavioral change.
Based on two previous qualitative studies (Zeliadt 2015; Kathuria 2018), we were
interested in whether patients’ misconceptions about LCS and smoking cessation would
be associated with static or negative smoking behaviors.We directly asked participants
about their thoughts on this. In particular, one study reported that discussions of LCS may
cause patients to have lower motivations to quit smoking (Zeliadt 2015). This finding is
opposite from the expected and desired outcome. Fortunately, and despite the belief their
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actual risk of lung cancer is higher than in reality, the patients in our study emphatically,
and sometimes even derisively, reported they would not negatively change their smoking
behaviors. Patients did not consider the LDCT to be a “green light” to continue to smoke.
Overall, we found that patients were not positively or negatively motivated to change
their smoking behavior based on the LCS decision-making discussion that included more
direct mention of lung cancer risk (usually in general terms) compared to other clinical
visits, suggesting that the LCS decision-making discussion is not harmful.
Based on clinicians’ descriptions and patients’ reports of their conversations,
clinicians did appear to use most of the 5A framework, although patients reported the
Assist and Arrange steps should only be utilized when the patient indicated a desire to
quit. Clinicians seemed to believe the use of the 5A’s were more important than patients.
This could be due to clinicians being more aware of the evidence behind use of the 5A’s.
In contrast to patient beliefs, clinicians placed more emphasis on discussing smoking
cessation during the LCS decision-making discussion. They felt it was a beneficial time
to communicate about the importance of cessation, whereas patients did not see a
difference compared to other encounters.
Despite the patient view of the discussion as comparatively less important than
clinicians, communication about cessation may still serve to improve self-efficacy and
trust, which has the potential to improve health behaviors. Indeed, self-efficacy is
influenced by communication and self-efficacy influences all aspects of behavior, not
only ceasing negative behaviors (Strecher 1986). If improved communication can lead to
improved self-efficacy it may be that patients will undergo other positive health behavior
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changes besides smoking, like maybe improved diet changes or decreased risky sexual
activity. Clinicians can also act upon self-efficacy through other ways beyond
communication, such as increasing self-esteem, anxiety, or depression. Therefore,
addressing these types of psychosocial factors may help to increase self-efficacy within a
clinical visit, possibly while communicating effectively about smoking. Importance of
self-efficacy is illustrated through patient responses that often implied their feelings of
readiness were most likely to produce behavioral change. Clinicians acknowledged this
importance as well, but still thought the 5A’s were an appropriate technique for
communicating about smoking cessation.
There may be other ways to frame the discussion with patients. For instance,
Assessing patients for their readiness to quit is essential to gauge their levels of selfefficacy. Importantly, when patients felt they were not ready to quit, they all reported
enough self-efficacy that they could obtain assistance when needed, but clinicians still
must ensure that patients realize they will be Assisted when they desire. Additionally,
instead of concentrating on lung cancer risk as a motivator for cessation, Advising might
incorporate discussion of risk for other smoking-related diseases, improvements to
quality and duration of life, financial or family related concerns, or subsequent increases
in negative emotional responses. Patients already knew that they were at high risk of lung
cancer - it was not new information.
Clinicians were surprised that discussion of lung cancer risk did not affect patients
smoking as much as expected, perhaps due to optimistic bias. For instance, if the risk of
lung cancer is less than expected, patients may feel a lesser risk compared to others,
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which might decrease distress and increase reassurance. Patients did not recall specific
lung cancer risk estimates, but the elevated risk of lung cancer was already acknowledged
by these patients. Typically, patients dramatically overestimated their risk. So, increasing
awareness of the personalized risks of other smoking-related diseases may be helpful, and
this type of information has been shown to lead to improved smoking behaviors in other
settings (Weinstein 1998; Baranowski et al. 1997; Kaminsky 2011). However, it may also
result in the opposite effect. Emphasizing smoking cessation may also decrease the
patient’s recollection of LCS-related information, as shown in the patients from Duke,
leading to no effect on smoking behaviors. Our findings also suggest clinicians do not
consider a discussion of the patient’s risk of cancer or other negative outcomes to be a
required component of Advise. Accordingly, this presents an opportunity for continued
investigation into how the 5A’s may be used to maximize communication and whether a
discussion of risk is needed.
Limitations
There are several limitations of this study. While the inclusion of multiple sites
increases the generalizability of the study, most of the cohort were Veterans. We
oversampled for minorities and women to address this limitation. This limitation may
also be mitigated because non-Veteran smokers who are eligible for LCS likely have
similar disadvantaged socioeconomic characteristics as Veterans (Kinsinger 2017; Aberle
2011). We found that many patients who declined to receive an LDCT were also
unwilling to participate in our research study, limiting our ability to evaluate those who
decline screening. However, we still reached saturation of the main themes. This study
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may suffer from selection bias. Duke University patient participants self-selected to
enroll in a cessation program and therefore were likely more motivated to quit even prior
to discussing LCS. This study also suffers from moderator acceptance and recall biases.
Timing of data collection may not capture all feelings and attitudes since each survey and
interview captures just one snapshot in time; however, the longitudinal design of this
study is intended to help compensate for this limitation. Follow-up interviews are ongoing, and findings will be subsequently published.
Conclusion
Our findings indicate that clinicians and patients differ on their view of lung cancer
screening discussions as an opportunity to communicate about smoking cessation. The
patient’s internal readiness to change and self-efficacy were agreed upon as more important
for a large behavior change like quitting smoking rather than emphasizing lung cancer
screening. Through continued utilization of the 5A’s, clinicians can improve
communication and thereby potentially increase trust and patient self-efficacy, which may
be especially important in hardened smokers.
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Table 1. Self-reported Patient Characteristics, n=51
Characteristic
Accepted LDCT
Treatment location
VA Portland Health Care System
VA Minneapolis
Duke University
Days after SDM (interview)
VA Portland Health Care System
VA Minneapolis
Duke University
Age (yr.)
Gender
Male
Race/ethnicity, n (%)
White
Black/African American
Hispanic
Refused
Marital Status
Married
Not Married
Smoking Status
Current Smoker
Former Smoker
Average Cigarettes per day
11-20
21-30
31 or more
Education, n (%)
High school or less
Some college or vocational work
College graduate or more
Employment status, n (%)
Retired, disabled, and/or currently not working
Employed (full time, part time, and/or irregular work)
Income, n (%)
$60,000 or more
Comorbidities (self-reported, could chose more than one)
Chronic Obstructive Pulmonary Disease (COPD)
Depression
Posttraumatic Stress Disorder (PTSD)
Asthma
*Percent’s are of non-missing data

N (%)* Or Mean (SD)
43 (84%)
19 (39%)
18 (35%)
14 (26%)
20.4 (16.6)
75.7 (60.6)
10.3 (4.9)
63 (5.83)
39 (76%)
41 (80%)
6 (12%)
2 (4%)
2 (4%)
18 (35%)
33 (65%)
33 (65%)
18 (35%)
28 (55%)
14 (27%)
9 (18%)
20 (39%)
26 (51%)
5 (10%)
30 (59%)
21 (41%)
12 (23%)
14 (31%)
19 (40%)
10 (22%)
3 (7%)
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Table 2. Clinician Self-reported Characteristics, n=24
Characteristic
Age (yr.)
Gender
Male
Female
Race
Caucasian
Asian
Black/African American
Specialty
Primary Care Provider/General Internist
Pulmonologist
Thoracic Surgeon
Radiologist
Physician Assistant
Nurse Practitioner/Registered Nurse
Years in Practice (since end of training)
0-10
11-20
>21
Site
Portland
Minneapolis
Durham
Years spent in current site
0-5
6-10
>11
Practice Setting
Government
University-Based
Type of Clinic
Internal Medicine/Primary Care
Pulmonary
Other
*Percent’s are of non-missing data and may not add up to 100%
due to rounding

N (%)* or Mean (SD)
42 (12.5)
8 (33%)
16 (67%)
18 (75%)
3 (13%)
3 (13%)
10 (42%)
3 (12%)
1 (4%)
1 (4%)
4 (17%)
5 (21%)
14 (58%)
5 (21%)
5 (21%)
8 (33%)
8 (33%)
8 (33%)
14 (58%)
4 (17%)
6 (25)
16 (67%)
8 (33%)
16 (67%)
4 (17%)
4 (17%)
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Chapter 5. Conclusion
Lung cancer remains an important public health concern, since deaths from lung
cancer makes up to 25% of all cancer deaths in the U.S. (American Cancer Society
2020).Cigarette smoking is one of the major contributing factors for lung cancer.
Therefore, although lung cancer screening (LCS) has been emphasized in an attempt to
identify an early detection of lung cancer, practically, reducing smoking prevalence is
often considered the best way to combat morbidity and mortality from lung cancer.
Smoking cessation is difficult but can considerably improve health outcomes (CDC
2020a).
The Centers for Medicare and Medicaid (CMS) mandated the LCS decisionmaking discussion when they initially approved LCS for funding in 2015. This mandate
occurred since decision-makers at the CMS believed in the importance of addressing
harms and benefits of screening. They also believed that the decision-making discussion
should help people understand the relevant risk factors of lung cancer, like smoking,
ensuring those eligible understand “the relevant risk factors and are engaged with the
shared responsibility regarding the decision to proceed or not” with the low-dose
computed tomography (LDCT) scan (Jensen et al. 2015). The LCS decision-making
discussion brings about an important opportunity for researchers to describe the
population offered LCS and also find out the importance of communication about
smoking within the decision-making discussion. It is unknown what factors are important
for improving smoking cessation among patients offered LCS.
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This dissertation research was designed to add to the literature of health
associated with smoking behaviors and contribute to applications of foundational theories
about smoking behaviors, smoking cessation, and hardened smokers offered LCS. This
dissertation addressed three specific research questions. First, what are the differences in
traditionally well-correlated socioeconomic and sociodemographic factors between
patients who were able to successfully achieve smoking cessation and those who were
not able to successfully achieve smoking cessation prior to the LCS decision-making
discussion?? Second, is patient-clinician communication (assessed by patient’s
perceptions of the presence of communication about smoking) during the LCS decisionmaking discussion associated with smoking cessation? The first two questions were
answered by quantitative analyses of patients involved in LCS decision-making
discussions. Through these analyses I was able to describe and compare factors
associated with successful smoking cessation using traditionally well-correlated
socioeconomic, sociodemographic, and psychosocial factors. Third, how do clinicians
and patients communicate about smoking within the LCS decision-making discussion?
This question was answered by undergoing a qualitative analysis of patient and clinician
interviews designed to elicit information on communication during the LCS decisionmaking discussion. Through this analysis I was able to further understand the use of the
LCS decision-making discussion as an opportunity to encourage smoking cessation.
I was able to use existing data from a longitudinal, observational, mixed-methods
cohort study of patients offered LCS in three institutions; VA Portland Health Care
System (VAPORHCS), Portland, OR; Minneapolis VA Medical Center, Minneapolis,
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MN; and Duke University Medical Center, Durham, NC. Given the unknowns thus far
about smoking behaviors in patients offered an LDCT for LCS, mixed-methods studies
may be particularly informative and useful (Creswell et al. 2011) since mixed-methods
can facilitate a rich and thorough understanding of unknown areas. Additionally, we
selected a mixed-methods design for the overall study in order to continually engage
patient and clinician stakeholders throughout the research process. The decision to use a
mixed-methods design improved the analytic plan and increased the potential to identify
tools and processes that could be broadly replicated.
Socioeconomic and Sociodemographic Factors, and Smoking Cessation
My first analysis answered the question: what are the differences in traditionally
well-correlated socioeconomic and sociodemographic factors between patients who were
able to successfully achieve smoking cessation and those who were not able to
successfully achieve smoking cessation prior to the LCS decision-making discussion? I
described characteristics of hardened smokers to add to the knowledge base about this
population and determine which socioeconomic and sociodemographic factors were
associated with former or current smoking. Then I compared these factors based on
smoking status (i.e., former vs. current smoker) at the time of the baseline survey. All
individuals were considered hardened smokers based on their smoking history – a
population that did not receive much scholarly attention in previous literature. My
findings showed that patients offered LCS, also considered hardened smokers, differed in
important social characteristics based on their smoking status at baseline. For example,
income was significantly lower for participants who currently smoked compared to
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participants who formerly smoked. Men were less likely to currently smoke than women,
and non-Hispanic whites were less likely to currently smoke than other races.
Cigarette smoking is more common among individuals with lower incomes and
consequently, they are disproportionately affected by smoking-related diseases (CDC
2020b). Findings from this study support prior research documenting the importance of
income as fundamental cause linked with health. Studies have shown that those who are
in poverty, when measured by income, are more likely to currently smoke (i.e., not
successfully quit). Not only do individuals below the poverty line attempt cessation less
often and are less successful at cessation, but low-income neighborhoods are more often
targets of tobacco advertising campaigns (CDC 2020b). Income provides key resources
like the ability to access safer and less targeted housing, purchase health care and more
nutritious foods (Adler and Newman 2002). Income also allows for greater access to
health information via technology like the internet. These types of amenities lead those
with higher incomes to greater levels of access to health information, which helps in
utilizing preventive medicine appropriately and avoid health risks, like smoking. Our
findings suggest that the link with poverty and continuation of smoking holds for
Veterans and civilians alike (Golden et al. 2018; Marmot and Wilkinson 2006). The
largest contributors to health are from a person’s behavior and their lifestyle (Adler and
Newman 2002), and income as part of SES impacts both of these contributors. My
findings add to the supporting evidence. Regarding behavior, people with lower income
may feel more socially isolated and lack in social support (Adler and Newman 2002).
These resources lead to more stress and worse health behaviors, like smoking. Those with
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limited income may not be able to live in locations that are conducive to health. For
instance, lower income may equate to worse environmental exposures like houses with
lead or asbestos. Income, indeed, as a fundamental cause affects many pathways toward
health.
Bruce Link and Jo Phelan (1995) described fundamental causes as social factors
that have four key elements. The first is that the mechanisms by which the factor
influences health may change, while the associations remain. This element highlights the
importance of a persistent connection in order to define a social variable as a
“fundamental cause.” The second element is that the factors must involve “access to
resources that can be used to avoid risks or to minimize the consequences of disease once
it occurs” (Link and Phelan 1995:87). The third key element is that the social factor must
influence multiple disease outcomes. That is, diseases ranging from cardiovascular
disease to lung cancer to HIV can be affected. Finally, the fourth element is that the
factor must affect diseases through multiple risk factors. Income determines the
availability of a good education, cleanliness and safety of the living environment, as well
as access to preventive health care. Fundamental causes, therefore, are the root of how
individuals are affected by disease and health.
My research also found that compared to women, men were less likely to be
currently smoking. One reason f may be the large sample of Veterans, who are mostly
men, enrolled in VA health care. Veterans enrolled in VA health care may have access to
more resources to aid in smoking cessation after military service than their civilian
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counterparts. Therefore men in our study may have more access to resources to help
them quit than women. Reasons for smoking initiation in the military are multifactorial
including stress relief, sanctioned regular smoking breaks, and peer pressure (Haddock et
al. 2009). Reasons for initiation may also be related to other military-specific factors such
as exposure to traumatic events or increased stress of deployment. A previous paper
found that sociodemographic factors associated with smoking status in Veterans were
similar to those observed in civilian populations. But there are also military-specific
findings suggesting that exposure to dead/dying/wounded soldiers, service era, duration
of service, service-connected disability status, and enrollment in VA care all influence
smoking in Veterans (Golden et al. 2018). Although these important variables were not
considered in the present study due to a limited sample size, they should be included in
future research to tease out the role of socioeconomic, sociodemographic, and militaryspecific variables in smoking cessation.
In addition, while smoking prevalence is generally lower for females, so is
successful cessation. Certainly, males have been found to have higher cessation rates
after participating in several randomized control trials of cessation interventions (Wetter t
al. 1999). It is possible that cessation interventions are more likely to help males, since
there are biological and/or social gender-specific issues that are not typically incorporated
into cessation intervention trials or therapies (Bottorff et. al 2014). In fact, there are
studies suggesting that certain interventions may work better for women. For example, a
study by Torchalla et al. (2012) found that cessation interventions that addressed weight
gain and weight concerns were most effective for women who wanted to quit smoking.
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Also, gender-specific interventions like psycho-pharmacologically differentiated
medications or psychiatric treatment focused on trauma-related substance abuse (Smith et
al. 2016), may be helpful for women. In contrast, more standard, gender-neutral
interventions, like counseling or use of medications like Wellbutrin (Botorff et al. 2014),
showed similar abstinence rates for both men and women.
The last statistically significant finding from this research question was that nonHispanic whites were less likely to currently smoke, consistent with previous research.
One study found that non-Hispanic blacks and other non-Hispanic youth were more
susceptible to smoking initiation compared to non-Hispanic whites (El-Toukhy, Sabado,
and Choi 2016) African-Americans who smoke menthol cigarettes (the most common
type of cigarette for African-Americans) have been found to have a more difficult time
successfully quitting (Stahre et al. 2010) despite more quit attempts (CDCb 2020). Many
differences in smoking rates can be explained by SES differences (Nollen, Mayo, and
Sanderson Cox et al. 2019). But additionally, institutional racism may interact with
cognitive biases of clinicians when faced with someone of a different racial or ethnic
group to affect their behavior and decisions (van Ryn et al. 2011), such as the decision to
offer cessation counseling during a clinician visit (Bailey et al. 2018; Reed and Burns
2008).
By understanding how and why people are exposed to risk factors and illness, as
well as how social factors are related to individual risk and disease, we can identify and
support the evidence for social factors (i.e., fundamental causes) that influence health
even after controlling for other mechanisms. For example, being homeless or
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experiencing discrimination based on race may provide the social context for
encouraging continued smoking, which may lead to development of lung cancer. That is,
it is important to realize the social factors leading to an individual’s homelessness or
discrimination (i.e., understanding how and why people are exposed to risk factors and
illness) as well as realize the mechanism of the behavior and disease. Power, prestige,
knowledge, money, and other interpersonal resources are significant players in the
fundamental cause theory of health and disease. These resources available to those in
higher SES levels or in majority races, for instance, are just so “extensive and wideranging” (Link and Phelan 1995) as to justify these factors as fundamental causes.
Resources are obtained and used in various ways, with the outcome being that they
directly shape individual health behaviors by influencing people’s access, knowledge,
and support about health behaviors.

Another more recent study found evidence supporting the fundamental cause
theory by looking at socioeconomic disparities in patients with lung cancer compared to
patients with pancreatic cancer. Lung cancer is a disease that is increasingly seen as
preventable due to the knowledge about smoking and increased focus on prevention and
cessation, whereas pancreatic cancer has a natural history that is largely unknown and
currently largely unpreventable. The authors wanted to test the fundamental cause theory
and hypothesis brought about by Link and Phelan that preventable diseases are more
sensitive to changes in social factors. The authors found that even though lung cancer
mortality rates were initially higher in counties with higher SES, “by 1980 persons in
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lower SES counties were at greater risk and by 2009 the difference in mortality between
counties with SES one SD above compared to one SD below average was 33 people per
100,000.” They also found a small but significant inverse SES gradient in pancreatic
cancer mortality, and that did not change over the time period studied. This supports the
hypothesis that social conditions more strongly influence preventable diseases and that
health inequalities occur due to differences in social conditions, like SES (Rubin,
Clouston, and Link 2014).

Interestingly, I did not find that education or employment status differed between
the two groups of hardened smokers, despite the evidence supporting these factors as
fundamental causes. Feldman et al. (1989) and Preston & Elot (1995) found that smoking
cessation rates increase with increased educational attainment. Education increases the
chances of having social support and develops human capital, which is an internal sense
of capital that can contribute to self-efficacy and confidence. Both social support and
human capital contribute to making positive health changes (Mirowsky and Ross
2015:299). In the Whitehall studies, Marmot examined a cohort of civil servants in the
United Kingdom, all with equal access to health care, stable jobs, and relatively free from
environmental hazards. Instead of finding that the seemingly similar occupational
conditions equated to similar health outcomes for this cohort, the researchers found that
there was a stark contrast in mortality between the top and bottom grades of civil workers
(Marmot et al. 1991). These findings support the theory that there must be resources and
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other positive characteristics of the workplace available only to those in higher ranks that
equate to better health (Burgard and Lin 2013; Mirowsky and Ross 2007).
Given the relatively older age of this sample (recruitment targeted those 55 and
older) and retirement status of this group, it is likely that factors such as education and
employment status may be less relevant with respect to smoking behavior. Since our
sample had been smoking for many years prior to being offered LCS and participation in
our study, the effects of these characteristics on smoking behaviors may have waned
while other characteristics became more prominent, such as more graphic warning labels
as deterrents (Azagba and Sharaf 2013; Shang et al. 2017), fear of withdrawal symptoms,
or desire for continued stress reduction (Baker, Brandon, and Chassin 2004).
Instituting universal health care for all would be a major way to reduce health
inequalities based on fundamental causes but is unlikely to occur in the US any time
soon. Marmot and Wilkinson (2006) suggest improving the “built environment” to
encourage more social interactions on a smaller scale, but policy recommendations often
include large-scale changes like improved social equity, equal access to education,
gender rights, state or federal investments in public health (Wright and Perry 2010), and
reduction of lobbying in government. Luckily, studies have shown that small, easy to
implement interventions are the most likely to reduce health inequalities (Phelan et al.
2010), so those are a good starting point for intervention. My findings can lead
exploration of possible mechanisms for these differences, and importantly, determine
mechanisms that might help with cessation. For example, it is possible that screening for
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income, race, and gender, prior to LCS decision-making discussions could be possible in
order to provide extra, or different, cessation strategies.
Based on these findings, I suggest that smoking cessation programs could tailor
their approach to patients while considering system- or individual- level characteristics
that influence smoking status, and smoking cessation. To address disparities between
income levels, gender, and race there may need to be 1) more global approaches to
equitably distributing key factors associated with positive health behaviors, such as
national system-level interventions to encourage income and racial inequality, and 2)
recognition and implementation of the gendered aspects of smoking cessation in
cessation interventions to address individual-level characteristics, like gender.
Communication and Smoking Cessation
The second question asked whether patient-clinician communication (assessed by
patient’s perceptions of the presence of communication about smoking) during the LCS
decision-making discussion is associated with smoking cessation. I used longitudinal data
to examine the association of communication about smoking within the LCS decisionmaking discussion with smoking cessation at one-year follow-up. I used valid and
reliable instruments to measure my variables of interest. I first summarized the
descriptive data for all measures for participants and performed bivariate statistics. I then
employed a logistic regression analysis to determine the association of presence of
patient-clinician communication with smoking status at one-year follow-up. I combined
the No discussion and Could Not Recall responses for our analysis. I was not able to
utilize a question more specific to the quality of communication since 53% of participants
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in this sample either could not recall or reported no, they did not have a decision-making
discussion. They, therefore, skipped the rest of the instrument and this would have greatly
reduced our sample size. However, even brief communication regarding smoking
cessation can have an impact on patient health behaviors (Lancaster and Stead 2004), and
arguably, the presence of communication is the first step in providing high quality
communication (IOM 2013).
It appears that communication about smoking within the LCS decision-making
discussion was not positively associated with successful smoking cessation. Instead,
while not statistically significant, it seems that individuals who could not recall or did not
report discussing smoking behaviors may be more likely to successfully quit smoking
after one year. My findings suggest that communication in the LCS decision-making
discussion about smoking was not effective as intended. Effective patient-clinician
communication has many benefits for both the health care system and the patient. But
patients may lack the necessary skills to ask relevant questions and to advocate for
themselves and their health. Clinicians also may lack necessary communication skills
(D'Agostino et al. 2017) that incorporate all domains of patient-centered communication.
All of the domains are amenable to training though, (D'Agostino et al. 2017) through
seven main pathways (Street et al. 2009) that can lead to better health outcomes, like
smoking cessation,. The seven main pathways are: increased access to care, improved
patient knowledge, higher quality medical decisions, patient understanding (therapeutic
alliance), increased social support, patient agency and empowerment, and better
management of emotions. Importantly, high quality patient-centered communication
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utilizing all domains will subsequently lead to improvements in all seven pathways that
can then lead to improved health behaviors.
A meta-analysis has shown that any type of communication within a cessation
intervention is more effective than self-help or no communication (Hollis et al. 2000).
These findings underscore that when clinicians ask patients about their smoking at any
encounter, it has been shown to lead to reduced smoking (Bailey et al. 2018; U.S.
Preventive Services Task Force 2017). Indeed, communication has been shown to lead to
improved smoking cessation. For example, Lindson-Hawley and colleagues found that
motivational interviewing is one form of communication that has been shown to lead to
improved smoking cessation (2015).
It is possible that all patients may have subconsciously picked up on the
importance of smoking cessation. More likely, they may have focused more on the fact
they were at high risk of lung cancer and realized that smoking cessation was the best
way to reduce their chance of being diagnosed with lung cancer. Additionally, anxiety
and distress, age, and perceived importance of medical information can all create
recollection issues, but even without these factors, “memory for medical information is
often poor and inaccurate” (Kessels 2003).But importantly, below my Research Question
3 shows that patients already realize that smoking causes lung cancer and want to make
the decision to quit personally (Golden et al. 2020). There seem to be other aspects of
smoking, social factors, and personal beliefs that more strongly influence smoking
behaviors, as evidenced by the findings to Research Questions 1 and 3.

155

I found that study site location was significant in this analysis, however, which
indicates that there is something different about individuals at Duke University compared
to the VAPORHCS. Study site location can be seen as a proxy for SES. Even though our
SES variables did not show a significant association with the outcome, our sites were
chosen purposively to collect data from diverse socioeconomic and sociodemographic
populations,Indeed, those with a lower SES are more often current smokers when
compared to those with a higher SES (Marmot and Wilkinson 2006). Duke University,
for instance, may have more private-pay patients, indicating that their patients may have
more resources available to quit smoking. Private-pay patients typically have higher
employment and may subsequently have higher economic resources overall. Those with a
lower SES are more often current smokers when compared to those with a higher SES
(Marmot and Wilkinson 2006), and those with a higher SES tend to have more resources
to utilize when they try to quit smoking. Low health literacy, indeed, effects an estimated
36% (80 million adults) of the US population (Kutner, Greenberg, and Baer 2006) and it
disproportionately impacts people from socioeconomically disadvantaged groups
(Mantwill, Monestel-Umana, and Schulz 2015; Hayward et al. 2000).
Study site location is also a proxy for willingness to quit smoking since Duke
University participants were recruited from a dedicated smoking cessation clinic. That is,
they proactively enrolled into a smoking cessation counseling clinic where LCS was
discussed within their smoking cessation clinical encounter. Participants at Duke,
therefore, were likely more motivated to quit smoking compared to the other sites since
they opted into a smoking cessation counseling clinic.
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Smoking during the LCS Decision-Making Discussion
My Research Question 3 asked: How do clinicians and patients communicate
about smoking within the LCS decision-making discussion? I performed qualitative semistructured interviews and conventional content analysis of both patients and clinicians.
These interviews focused on communication regarding smoking, the perceived
importance of discussing smoking and screening together, and perceived patient
challenges to cessation. I learned that clinicians and patients differed on their views about
LCS decision-making discussions as an opportunity to communicate about smoking
cessation.
My qualitative findings in Research Question 3 supported my quantitative results
that communication about smoking during the LCS decision-making discussion is
unlikely to influence smoking behavior. I found through the qualitative interviews that,
even though clinicians seemed to mostly adhere to the 5A framework, there are other
more meaningful factors related to smoking cessation for patients. For instance, patients
mentioned personal reasons like finances or family as reasons to quit smoking rather than
the risks of lung cancer or other health problems. These factors are not currently being
leveraged by current clinician communication practices to motivate positive behavioral
change.
While clinicians varied in their report of the use of the 5A’s during LCS decisionmaking discussion, most described using at least parts of the 5A framework every time.
All clinicians reported it was important to discuss smoking, some particularly within the
LCS decision-making discussion. In contrast, patients described talk about smoking as
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“expected,” but it did not influence their desire to quit or abstain from smoking. They did
not see the difference between communication about smoking during the LCS decisionmaking discussion compared to during other clinical encounters. Patients emphasized
personal feelings of readiness and self-efficacy.
Notably, lack of self-efficacy can lead to poorer management of stress, which can
then lead to poorer health behaviors, like smoking. We know from the abundance of
research done on the impact of stress on the allostatic load and health, that chronic stress
in particular can increase the incidence of heart disease, stroke, arterial disease, infection,
and even mortality (Marmot and Wilkinson 2006). Higher senses of self-efficacy also
lead to less smoking relapse (Baer, Holt, and Lichtenstein 1986; Condiotte and
Lichtenstein 1981; O'Leary 1985), general positive health behavior changes (Strecher et
al. 1986), and other health benefits like improved pain experience and management, and
better adherence to preventive programs and recovery from heart conditions (O'Leary
1985). A motivated and self-efficacious patient will likely be more empowered to be an
activated patient involved in their health, but they will also be more likely to be able to
make healthy changes on their own, like quitting smoking (Bandura 1997). Indeed, other
studies have shown health outcomes affected by levels of self-efficacy such as in overall
ratings of health (Grembowski et al. 1993), engagement in cancer screenings (Seyde,
Taal, and Wiegman 1990), and alcohol use (Christiansen, Vik, and Jarchow 2002). Since
patients offered LCS may be more engaged patients given they are interacting with the
health care system to discuss LCS, they may have more self-efficacy. Higher self-
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efficacy may account for the finding that patients felt empowered to seek out assistance
for smoking cessation if and when they were ready.
Clinicians can boost self-efficacy to help patients quit smoking through
continued, and repeated, use of the 5A’s during every clinical encounter, especially via
Assessing and Advising their patients. One finding showed that clinicians do not consider
discussion of risks of disease as a required component of the Advise aspect of the 5A’s.
Consequently, although clinicians seemed aware of the 5A’s, more education may be
necessary or desired to garner the desired impact. One possibility might be to use a
computer-facilitated 5A’s delivery model that has recently been shown to improve the
fidelity of the 5A framework within primary care (Satterfield et al. 2018). There are other
online variations that illustrate the impact the 5A’s can have on patients (Martinez et al.
2019) as well that may be helpful.
Further, clinicians could not only continue to use the 5A’s, but they could
maximize their impact. For instance, since patients reported that they already knew they
were at a higher risk of lung cancer compared to people who never smoked clinicians
might educate patients about risks of other smoking-related diseases like rheumatoid
arthritis or obstructive lung disease (Gath et al. 2018; Parkes et al. 2008) instead of
emphasizing lung cancer risk as motivation for cessation. . Another option might be to
pair the 5A’s with a personal motivator like financial incentives, if possible (Olson,
Boardman, and Johnson 2019).
Strengths and Contributions
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Some strengths of this dissertation include the available data. I was able to use a
unique, available dataset that provided information on patients offered LCS within three
diverse LCS programs. We used valid and reliable surveys as well as widely used
measures of health outcomes which supported the scientific integrity of the study. In
addition, this study was novel as there has never been a mixed-methods study in this area.
It is also novel since the population of hardened smokers has never been described and
compared, and there has been little research on the association of smoking outcomes with
communication in the context of LCS decision-making discussions. Longitudinal studies
are beneficial because they can account for static subject characteristics that may
influence cross-sectional research leading to spurious results. The focus is timely as LCS
is still in the early stages of implementation and smoking rates remain high in the United
States.
Limitations
This dissertation is not without limitations. First, while the inclusion of multiple
sites increases the generalizability of the study, there remains a limitation due to the
majority of the cohort being Veterans. Veterans are more likely to be male and
Caucasian. We oversampled for minorities and women in the qualitative interviews to
address this limitation. Second, I was not able to compare people offered LCS versus
those who were not offered LCS given the parameters of the original study. I was also not
able to examine individuals who had never smoked for their thoughts on smoking since
they are not currently offered LCS. By not including those not offered LCS and those
who never smoked I was not able to capture their thoughts and responses to see if they
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were affected differently by the LCS decision-making discussion. The discussion itself
could have greatly impacted smoking cessation, or even never smokers’ thoughts on
smoking and/or LCS. It would be useful to incorporate these groups in future research.
Third, this study suffers from reporting bias, in that those who participate may be
more likely to report higher incidence or quality of communication. This may have
impacted our findings to show a bias towards presence of communication. Future
research in this area could benefit from audio or visual confirmation of communication
about smoking occurring during the LCS decision-making discussion. The fourth
limitation is selection bias. We found that patients unwilling to undergo the LDCT were
also unwilling to participate in our research study, limiting our ability to document those
who decline screening. Participants agreeing to undergo the LDCT will likely have
significant differences compared to participants who decline to undergo the LDCT and
should be investigated further. However, our previous qualitative work among Veterans
and non-Veterans has uncovered similar themes about deficits in patient-centered care
(Golden et al. 2016). Fifth, this study suffers from recall bias; it is possible that
participants may not recall, or want to recall, certain items. Participants might say what
they think the researchers want to hear, also called moderator acceptance bias. Timing
may not capture overall feelings since each survey and interview captures just one
snapshot in time. Finally, I did not investigate specific mechanisms in this dissertation.
Even so, it remains imperative to first determine the association of perceived
communication with a health outcome, which will be a foundation for future studies
about proximal and intermediate outcomes.
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Future studies can be guided by the findings presented in this dissertation. For
instance, health promotion literature indicates that targeting specific subgroups of people
with health-related messages may work better than large-scale canvassing (Latimer,
Salovey, and Rothman 2007). Therefore, talking to specific groups of patients who
smoke may influence them more than other types of cessation advertising or
recommendations. By targeting those within LCS and using cessation-related messages
that are tailored to their specific subgroup or characteristics, we may be able to help
certain populations successfully quit smoking in future studies designed to develop
interventions.
Conclusions and Implications
To conclude, findings of this dissertation drive three conclusions. First, hardened
smokers offered lung cancer screening differed in important social factors based on their
smoking status at baseline. Smoking cessation programs may need to tailor their
approach to patients offered LCS who may have other individual- or system- level
characteristics that influence the association between socioeconomic and
sociodemographic factors, smoking status, and smoking cessation. Second, discussing
smoking cessation during the LCS decision-making discussion may not lead to successful
smoking cessation at least in the short term. There may be other more important aspects
that affect smoking cessation, like encouragement from family and friends or financial
reasons. Lastly, in support of previous findings, communication about smoking during
the LCS decision-making discussion is unlikely to influence smoking behavior.
Importantly, these findings add to the knowledge base and sociological theory about
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fundamental causes, unique populations, like hardened smokers, and patient-clinician
communication.
Despite the fact that there is no evidence base for the shared decision-making
mandate for LCS, there has been encouragement from Wender et al. (2013) on behalf of
the American Cancer Society and others regarding use of shared decision-making for
cancer screenings in general (Joosten et al. 2008). For example, the Institute of Medicine
published a report promoting incorporation of patient-centered care, of which shared
decision-making is a key piece (2013). Shared decision-making, certainly, is a component
of high-quality communication (Mead and Bower 2000). A review in the New England
Journal of Medicine explained that shared decision-making may be especially useful for
ensuring patient-centered care within cancer screening discussions where there is no clear
“right” answer (Barry and Edgman-Levitan 2012). It may be, though, that the mandate
and implementation of the LCS decision-making discussion to include communication
about smoking is not being conducted as intended or not having the effect expected.
Broader implications from this dissertation show that other, more personalized
approaches may need to be used during clinical encounters in order to help patients
abstain or quit smoking such as motivational interviewing or counseling. This finding
may affect the smoking component of the shared decision-making mandate for LCS
itself.
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Appendix A. VA Decision Aid
https://www.prevention.va.gov/docs/LungCancerScreeningHandout.pdf
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Appendix B. Duke University Decision Aid
https://radiology.duke.edu/wp-content/uploads/2020/08/Lung-Cancer-Screening-SharedDecision-Making.pdf
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Appendix D. Selected Surveys
1. About You
This section is about your background. Please check one box unless otherwise indicated.
1. What is the highest level or grade of school you have completed?
1st-8th grade

Some college or vocational work

9th-11th grade

College graduate

High school graduate (12th grade)/GED

Post-graduate work

Refused
2. Are you currently employed? Check all that apply.
Employed full time (35+ hrs/wk)

Retired

Employed part time, regular work

Disabled

Employed part time, irregular work

Currently not working

Unemployed, looking for work

Volunteer work

Student

Other, specify: _______________________

Refused
3. How would you describe your current marital status?
Never married

Separated

Married

Widowed

Divorced

Refused
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4. How would you describe your racial/ethnic background?
American Indian/Alaska Native

Black/African American

Asian

White/Caucasian

Native Hawaiian/Other Pacific Islander

More than one race

Other, specify:

Refused

______________

5. Are you Spanish, Hispanic, or Latino?

Yes

No

Refused

6. What is the average total yearly income for your household? (Include all income)
Less than $10,000

$40,000 - 49,999

$10,000 - 19,999

$50,000 - 59,999

$20,000 - 29,999

$60,000 - 69,999

$30,000 - 39,999

$70,000 – 79,999

$80,000 or more

Refused

8. With which gender do you identify?

Male

Female

Refused

11. Tobacco Use
1. How would you describe your cigarette smoking?
Never smoked (less than 100 cigarettes
Past smoker (quit over Current smoker (any smoking, even a puff,
in your lifetime)

7 days ago)

within the past 7 days)

For current smokers:

12. Screening and Smoking (If no/can’t recall to discussion, skip to section 13)
1. Did the person who talked with you most about screening discuss quitting smoking
[electronic cigarettes] with you?
Yes

No (skip to section 13)

Can’t recall

Does not apply
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Appendix E. Interview Guides

PATIENT INITIAL INTERVIEW
Lung Cancer Screening Implementation: Evaluation of Patient-Centered Care
Qualitative Study

Study ID
Interview Date

/

/

Interviewer(s)

Smoking
•

•
•
•
•

•

•
•

How does lung cancer screening (LCS) make you think about your smoking and
health? Are there effects of smoking besides lung cancer?
o How did your clinician communicate about smoking during your
discussion?
o What were your reactions
What are your thoughts on screening as a substitute for cessation?
o Probe for barriers to cessation, personal risks.
Does a negative test mean you don’t have bad effects from smoking?
If the PCP asked, advised, assessed, assisted (counseling, talking, recommending
meds, etc.) and arranged f/u for smoking, would that help?
How do you feel about former smokers being offered LCS?
o Get thoughts on smoking status during screening (providers more willing
to discuss, does/should it matter, etc.)?
How important is it that everyone at the [your institution] is offered screening if
they're eligible vs. just leaving it up to the individual PCP and patient decisions?
o That is, what would happen if there were no clinical reminders?
Do you think doctors “push” lung cancer screening for their patients?
Do you think their personal views on smoking influence their decisions to offer
screening to their patients?
o Why?
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•
•

Do you feel like your smoking status affects how health care providers treat you?
How does your smoking status affect your care or choices offered to you?
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CLINICIAN INTERVIEW
Lung Cancer Screening Implementation: Evaluation of Patient-Centered Care
Qualitative Study

Study ID
Interview Date

/

/

Interviewer(s)

Smoking
•
•
•
•
•
•

How do you address smoking cessation during screening or after the CT?
o What would help you to do a better job?
o How do you feel this process influences your patient’s desire to quit?
How do you think patients understand smoking and health? (e.g. Do they
understand other effects beside lung cancer?)
Do you generally recommend screening for most patients who meet criteria?
Do you think stigma against smokers influences your or other clinicians’
opinions?
Tell me about how you address a patient’s concerns and worries after the LDCT.
How do screening results typically affect your patients?
o Does it matter if the results are negative or positive?
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Appendix F. Human Subjects Approvals
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